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ABSTRACT / RESUMO
Multiple sclerosis is one of the most frequent neurological non-traumatic 
causes of progressive disability in the young adult. The disease process is of 
autoimmune inflammatory nature attacking antigens of oligodendrocites 
and myelin sheaths. This results in destruction of myelin and eventually 
neurodegeneration in the central nervous system. Early reports stated that 
pain is uncommon among the constellation of symptoms of multiple sclerosis, 
but it soon became evident that the majority of patients experience pain. Pain 
syndromes in this disease are varied, and may be either nociceptive or neuropathic, 
the later believed to be the most common. Concerning neuropsychiatric and 
neuropsychological abnormalities, depression and cognitive dysfunction are 
the most pressing problems in multiple sclerosis. Patients present often, as 
well, altered decision-making and emotional reactivity that may be related to 
impaired reward valuation and altered ability to assess long-term consequences 
of decisions.
We aimed to examine pain associated with multiple sclerosis, still poorly 
understood. More specifically, our objectives were to characterise the Portuguese 
reality of pain in these patients; assess the use of neuroimaging studies in the 
research of pain in multiple sclerosis; investigate the potential of various functional 
and structural magnetic resonance imaging techniques; study central chronic 
neuropathic pain of multiple sclerosis, unravelling etiological pain mechanisms 
and the consequences of chronic pain in the brain, using neuroimaging measures; 
investigate resting functional brain changes associated with chronic pain in this 
condition, in particular those related to cognition and affect.
We have studied two multiple sclerosis patient cohorts, Portuguese (Centro 
Hospitalar São João, Porto) and British (John Radcliffe Hospital, Oxford). Eighty-
five multiple sclerosis patients participated in the Portuguese study. In the British 
project, 12 multiple sclerosis patients with chronic neuropathic central pain were 
compared with 11 patients with multiple sclerosis without pain.
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This dissertation includes five main chapters. In the first chapter, we describe 
the demographic and clinical characteristics, with an emphasis on pain, of the 
Portuguese cohort, contributing to pain epidemiology in multiple sclerosis. We 
have found a prevalence of pain of 34%. Anatomically, the most common pains 
were headache and back pain, and pain interfered significantly with general activity, 
mood, work, social relations, and enjoyment of life. Pain is an important symptom 
in Portuguese patients with MS, not only because of the high prevalence found, 
concordant with other European countries, but also because of its interference 
with quality-of-life.
In the second chapter, we reviewed the existing literature on neuroimaging 
studies investigating pain in multiple sclerosis, hoping to provide a context to our 
neuroimaging British project. We retrieved 34 small studies of variable quality, 
most of which reported a neuroradiological association with neuropathic pain. 
There was a bias towards headache/facial pain, with brainstem lesions most 
frequently reported. Almost all studies used structural magnetic resonance 
imaging, without functional or molecular techniques, despite the great potential 
of these to unravel noninvasively pain mechanisms. Besides, the description of 
image acquisition and reading protocols was generally either insufficient or non-
existent.
In the third chapter, we investigated the potential of various brain functional 
and structural magnetic resonance imaging techniques. Structural neuroimaging, 
deals with the structure of the central nervous system and is important for the 
diagnosis of focal lesions of the brain. In general it is highly reproducible and 
accurate. Its sensitivity and specificity with respect to pathology is a major concern: 
image quality is particularly dependent on image resolution, contrast, signal-
to-noise ratio and lack of image artifacts. Structural imaging is also important 
in communicating neuroimaging results with reference to brain anatomy. The 
accuracy, reliability, validity and limitations of neuroimaging are more acute 
issues in functional imaging. Assumptions behind the different techniques, design 
and theory of research, reliability and validity of tasks, head motion, hardware 
and software diversity, lack of normative procedures, statistical issues, and 
interpretation of results, all have an impact in functional imaging results.
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The work chapters four and five represent refer to the British patient cohort, 
comparing multiple sclerosis patients with and without chronic central neuropathic 
pain. The fourth chapter was dedicated at studying the etiological pain mechanisms 
and the consequences of chronic pain in the brain of patients using neuroimaging 
measures.Lesion location that most often explained pain was the spinal cord, and 
the thalamus seemed not to be an important source of central pain. Concerning 
possible consequences of chronic neuropathic pain, we have showed evidence of 
brain structural and functional dysfunction: increased connectivity between brain 
regions involved in pain processing, a decreased volume of normal-appearing 
white matter, myelin disorganisation, and increased perfusion in the primary 
somatic area. We believe these plastic, probably maladaptive, brain changes 
may be a contribution of chronic pain, and furthermore, a consequence of pain 
originating in the spinal cord in multiple sclerosis.
Finally, examining functional changes in the context of central chronic pain 
of multiple sclerosis, we have investigated its impact on the resting brain. We have 
found a default-mode network (believed to be important in planning the future and 
in social interactions) dysfunction in regions subserving the reward system, the 
caudate nucleus and nucleus accumbens, suggesting altered decision-making in 
these patients.
Taken together, the results presented in this thesis demonstrate that pain 
is an important symptom also in Portuguese patients with multiple sclerosis, and 
that despite the value of neuroimaging in studying pain and multiple sclerosis 
noninvasively, literature is still scarce in the field. As evaluated with magnetic 
resonance imaging, spinal cord lesions seem to be a common cause of multiple 
sclerosis central pain. Regarding the consequences of chronic pain in the 
brain, there is evidence of different pain conditions inducing distinct structural 
and functional patterns. The brain changes found in our work may reflect the 
uniqueness of pain in multiple sclerosis, exposing not only pain processes but 
also the specific pathology of this disease.
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A esclerose múltipla é uma das causas neurológicas não traumáticas mais 
frequentes de incapacidade progressiva do adulto jovem. O processo patológico 
é de natureza inflamatória auto-imune com envolvimento dos oligodendrócitos e 
das bainhas de mielina, o que resulta na destruição da mielina e, eventualmente, 
em fenómenos neurodegenerativos do sistema nervoso central. As primeiras 
descrições afirmavam que a dor é pouco comum entre a constelação de sintomas 
desta doença, mas cedo se tornou evidente que a maioria dos doentes experiencia 
dor. Os síndromes dolorosos na esclerose múltipla são variados, e podem ser de 
tipo nocicetivo ou neuropático, o último acreditando-se ser o tipo mais frequente. 
Em relação às perturbações neuropsiquiátricas e neuropsicológicas desta 
doença, os problemas mais prementes são a depressão e a disfunção cognitiva. 
Estes doentes apresentam também comumente alterações da capacidade de 
tomada de decisão e de reatividade emocional, que podem estar relacionados 
com perturbação da capacidade de avaliação da recompensa e da capacidade de 
perceber as consequências a longo prazo das suas decisões.
O nosso objectivo foi examinar a dor associada à esclerose múltipla, ainda 
pouco estudada. Mais concretamente, os nossos objectivos foram caracterizar a 
realidade portuguesa da dor nestes doentes; avaliar a sua investigação por estudos 
de neuroimagem; investigar o potencial de várias técnicas de imagem funcional 
e estrutural por ressonância magnética; estudar a dor crónica neuropática 
central da esclerose múltipla, desvendando mecanismos etiológicos da dor e 
as consequências encefálicas da dor crónica utilizando métodos de imagem; 
investigar alterações cerebrais funcionais em repouso associadas à dor crónica 
desta doença, em particular aquelas relacionadas com a cognição e o afeto.
Estudamos duas amostras de doentes com esclerose múltipla, uma 
portuguesa (Centro Hospitalar São João, Porto) e outra britânica (John Radcliffe 
Hospital, Oxford). Participaram 85 doentes com esclerose múltipla no estudo 
português. No projeto britânico, 12 doentes com esclerose múltipla e dor crónica 
neuropática central foram comparados com 11 doentes com esclerose múltipla 
sem dor.
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Esta dissertação inclui cinco capítulos principais. No primeiro capítulo, 
descrevemos as características clínicas e demográficas, com ênfase na dor, da 
amostra de doentes portuguesa, contribuindo assim para a epidemiologia da dor 
na esclerose múltipla em Portugal. Encontramos uma prevalência de dor de 34%. 
Anatomicamente, os tipos de dor mais comuns foram a cefaleia e a dor do dorso, 
e a dor interferiu significativamente na atividade geral, o humor, o trabalho, as 
relações sociais e o prazer da vida. A dor é um sintoma importante nos doentes 
portugueses com esclerose múltipla, não apenas por causa da elevada prevalência 
encontrada, concordante com a de outros países europeus, mas também pela 
sua interferência na qualidade de vida destes indivíduos.
No segundo capítulo, revimos a literatura existente de estudos de 
neuroimagem na investigação da dor na esclerose múltipla, tentando atribuir um 
contexto ao nosso projeto britânico de neuroimagem. Encontramos 34 pequenos 
estudos de qualidade variável, a maioria dos quais reportava uma associação 
neurorradiológica de dor neuropática. Existiu um viés na descrição de cefaleias/
dor facial, sendo as lesões do tronco cerebral aquelas mais referidas como causa. 
A maioria dos estudos utilizou técnicas de imagem por ressonância magnética 
estrutural, sem recorrer a métodos funcionais ou moleculares de imagem, 
apesar do grande potencial destas técnicas na investigação não-invasiva dos 
mecanismos de dor. A descrição da aquisição das imagens e dos protocolos de 
leitura das mesmas foi em geral insuficiente ou mesmo ausente.
No terceiro capítulo, investigamos o potencial de vários métodos de imagem 
por ressonância magnética estrutural e funcional. A neuroimagem estrutural 
examina a estrutura do sistema nervoso central e é importante no diagnóstico 
de lesões focais encefálicas. Em geral é bastante reprodutível e precisa. Existe 
preocupação com a sua sensibilidade e especificidade em relação à patologia: 
a qualidade da imagem é particularmente dependente da resolução, da 
relação sinal-ruído, e da ausência de artefatos. A imagem estrutural é também 
importante na comunicação de resultados em função da anatomia cerebral. 
A precisão, fiabilidade, validade e limitações imagiológicas são problemas 
mais agudos quando nos referimos aos estudos funcionais. As assunções das 
diferentes técnicas, o desenho e a teoria da investigação, a fiabilidade e a validade 
das tarefas, o movimento da cabeça, a diversidade de hardware e software, a 
ausência de procedimentos normativos, problemas estatísticos e a interpretação 
dos resultados, todos têm um impacto nos resultados de imagem funcional.
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O trabalho do quarto e quinto capítulos refere-se à amostra britânica de 
doentes, em que se comparam doentes com esclerose múltipla com e sem 
dor crónica neuropática central. O quarto capítulo foi dedicado ao estudo dos 
mecanismos etiológicos e das consequências encefálicas da dor crónica utilizando 
medidas de neuroimagem. As lesões que mais frequentemente explicaram a dor 
localizavam-se no cordão medular, e o tálamo não foi uma fonte importante de 
dor central. Em relação às possíveis consequências da dor crónica, mostramos 
evidência de disfunção estrutural e funcional cerebral: aumento da conectividade 
entre regiões cerebrais envolvidas no processamento da dor, redução do volume da 
substância branca de aparência normal (ressonância magnética), desorganização 
da mielina, e aumento da perfusão na área somática primária. Acreditamos que 
estas alterações cerebrais plásticas, provavelmente mal-adaptativas, podem ser 
uma contribuição da dor crónica, e também a consequência de dor com origem na 
espinal medula.
Finalmente, ao examinar as alterações funcionais no contexto da dor crónica 
central da esclerose múltipla, investigamos o seu impacto no encéfalo em 
repouso. Descobrimos uma disfunção da default-mode network (implicada 
no planeamento do futuro e nas interações sociais) em regiões do sistema de 
recompensa, mais precisamente no núcleo caudado e no núcleo accumbens, o 
que sugere perturbação da capacidade de tomada de decisão nestes doentes.
No seu conjunto, os resultados apresentados nesta tese demonstram que a dor é 
um sintoma importante também em doentes portugueses com esclerose múltipla, 
e que apesar do valor da neuroimagem no estudo da dor e da esclerose múltipla 
não invasivamente, a literatura é ainda pobre nesta área. Como avaliado por 
ressonância magnética, as lesões da espinal medula foram a causa mais frequente 
de dor central. quanto às consequências da dor crónica no cérebro, há evidência 
de que diferentes condições dolorosas induzem padrões estruturais e funcionais 
distintos. As alterações cerebrais encontradas no nosso trabalho podem assim 
refletir a singularidade da dor da esclerose múltipla, expondo não só os processos 
da dor mas também os mecanismos patológicos específicos desta doença.
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ABBREVIATIONS
ASL Arterial spin labeling
BOLD Blood oxygen level dependent
BPI Brief pain inventory
CBF Cerebral blood flow
CNS Central nervous system
CRPS Complex regional pain syndrome
CSF Cerebrospinal fluid
DIR Double inversion recovery
DMN Default-mode network
DTI Diffusion tensor imaging
DWI Diffusion-weighted imaging
EAE Experimental autoimmune encephalomyelitis
EDSS Expanded disability status scale
FAST FMRIB’s automated segmentation tool
FEAT FMRI expert analysis tool
FIRST FMRIB’s integrated registration and segmentation tool
FLAIR Fluid-attenuated inversion recovery
FLIRT FMRIB’s linear image registration tool
FMRI Functional magnetic resonance imaging
FMRIB Oxford centre for functional magnetic resonance imaging of the brain
FNIRT FMRIB’s nonlinear image registration tool
FSE Fast spin-echo
FSL FMRIB’s software library
HADS Hospital anxiety and depression scale
IASP International association for the study of pain
ICA Independent component analysis
MFIS Modified fatigue impact scale
MPRAGE Magnetisation-prepared rapid acquisition gradient echo
MRI Magnetic resonance imaging
MS Multiple sclerosis
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MSNQ Neuropsychological screening questionnaire
MWF Myelin water fraction
NAWM Normal-appearing white matter
PET Positron emission tomography
QOL qality-of-life
QST quantitative sensory testing
RR Relapsing-remitting
RSN Resting-state network
SF36 The short form (36) health survey
SPECT Single photon emission computed tomography
SE Spin-echo
TN Trigeminal neuralgia
VBM Voxel-based morphometry
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1.1. MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is a severe chronic neurological disease that causes 
serious handicap and suffering, and is one of the most frequently observed 
neurological non-traumatic causes of progressive disability in the young adult. 
MS is triggered by environmental factors in individuals with complex genetic-
risk profiles, and the disease process is of autoimmune inflammatory nature, 
mediated mainly by T-cells that attack antigens of oligodendrocites and myelin 
sheaths (Compston A and Coles A, 2008). This results in destruction of myelin 
and eventually of the axons and cell bodies in the central nervous system 
(CNS). The characteristic histopathological lesion is the plaque, which is a zone 
of demyelination. Such plaques may occur anywhere in the CNS, but are most 
frequently found in the spinal cord, particularly in the dorsal columns, in the 
brainstem, and in the white matter around the ventricles in the forebrain. Apart 
from the white matter lesions that are easily detected by imaging techniques, 
pathological studies showed that extensive cortical and deep grey matter areas 
are demyelinated in MS patients (Stadelmann C et al, 2008).
The plaque-centered view of the disease fails to explain clinical deterioration 
of the patients when they have reached the progressive stage of the disease. It 
was thus postulated during the past years that besides inflammation there is a 
neurodegenerative component of the disease that leads to progressive and global 
brain damage (Lassmann H, 2007). There is increasing evidence that the severity 
of the clinical manifestations of MS does not simply depend on the extent of tissue 
destruction, but rather represents a complex balance among tissue damage, 
tissue repair, and cortical reorganisation (Figure 1).
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figure 1. The course and pathogenesis of multiple sclerosis. The scheme illustrates how the pathological 
processes of inflammation, demyelination, and axon degeneration explain the clinical course of the disease 
(arrows indicate the progression of pathology). Central nervous system inflammatory activity might precede 
clinical symptoms by many years. The first pathological event is lymphocyte-driven inflammation (A: 
lymphocytes are seen around a blood vessel, haematoxylin and eosin stain). This inflammation might impede 
the saltatory propagation of the action potential (arrowheads) in three ways: soluble inflammatory mediators 
might cause conduction block in structurally intact axons (A), or there may be demyelination (B: luxol fast 
blue myelin stain showing very early lesion with several macrophages laden with myelin and some intact 
myelinated nerves), or axonal transection (C: non-phosphorylated neurofilaments [SMI32 staining] marks 
terminal axon spheroids). Microglia are activated, and contribute to inflammation and to repair by removal 
of myelin debris and promotion of remyelination (F: oligodendrocyte with proteolipid protein mRNA [black] 
connected to remyelinated axon with proteolipid protein immunoreactivity [red]). If this fails, persistently 
demyelinated axons adapt by redistributing ion channels (E: sodium-channel redistribution along denuded 
axons, antipan Nav channel antibody [green], antineurofilament [red]), which might prove maladaptive and 
promote chronic neurodegeneration (G: confocal of a shadow plaque, with a remyelinating oligodendrocyte 
[red-proteolipid protein antibodies], and degenerating unmyelinated axons [green-neurofilament antibodies]). 
Microglia can become chronically activated, in the absence of lymphocytic inflammation, in areas of normal 
appearing white matter and also lead to neuronal loss in later stages of the disease (D: CD68+ microglia). In 
response to chronic tissue injury, astrocytes cause gliosis, which can act as a mechanical barrier for repair 
(H: haematoxylin and eosin stain). Not depicted is primary progressive multiple sclerosis in which there is 
significant axonal degeneration with or without a preceding inflammatory phase. Reproduced with permission 
from Compston and Coles, 2008.
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The early course of the disease is characterised by episodes of neurological 
dysfunction that usually recover. However, over time the pathological changes 
become dominated by widespread microglial activation associated with extensive 
and chronic neurodegeneration, the clinical correlate of which is progressive 
accumulation of disability (Compston A and Coles A, 2008). In most patients, 
clinical manifestations indicate the involvement of motor, sensory, visual, and 
autonomic systems but many other symptoms and signs can occur. MS first 
symptoms are frequently of the sensory type, like hypoesthesia (reduced sensitivity 
to cutaneous stimulation) or paresthesia (subjective cutaneous sensations 
experienced spontaneously) that starts in an extremity, and progress over days 
to involve an entire limb. Symptoms usually remain stable for one or two weeks, 
and then resolve gradually. Other common symptoms at presentation are blurred 
vision, diplopia, vertigo, motor deficits and ataxia. Few of the clinical features 
are disease-specific, but particularly characteristic is Lhermitte’s symptom (an 
electrical sensation running down the spine or limbs on neck flexion) and the 
Uhthoff phenomenon (transient worsening of symptoms and signs when core 
body temperature increases) (Compston A and Coles A, 2008).
The clinical evolution of MS is somewhat predictable, occurring usually in 
relapses in the first years of the disease, with remission of the symptoms and signs 
(relapsing-remitting – RR), and then becoming progressive with time (secondary 
progressive MS). There are also other subtypes of the disease, more aggressive, 
like remittent-progressive MS (where the signs and symptoms of the disease do 
not abate completely after each relapse), and primary progressive MS, that lacks 
the characteristic episodic evolution, being progressive ad initium. An additional 
form of the disease is the denominated clinically isolated syndrome, representing 
the first neurological episode of the disease (Lublin FD and Reingold SC, 1996).
In all cases, the clinical course usually evolves over several decades. Death is 
attributable to MS in two-thirds of cases and to the increased risk of infection and 
its complications in individuals with advanced neurological disability; the median 
time to death is around 30 years from disease onset, representing a reduction in 
life expectancy of 5-10 years (Bronnum-HansenH et al, 2004).
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A recent revision of the disease diagnostic criteria (Polman CH et al, 2011) 
allows earlier diagnosis, which avoids incorrect attribution of symptoms and signs 
in young adults to MS, and permits timely discussion about management. Clinical 
evidence is sufficient for establishment of the diagnosis, but when the diagnosis is 
ambiguous, complementary studies may help decision-making: evoked potentials, 
protein electrophoresis of the cerebrospinal fluid (CSF) and magnetic resonance 
imaging (MRI). MRI shows focal or confluent abnormalities in white matter in 
more than 95% of patients (Compston A and Coles A, 2008). Their presence alone, 
however, does not make the diagnosis of MS; characteristic radiological lesions can 
appear in people without clinical signs of disease and many older individuals have 
non-specific white matter cerebral lesions, which should not be over-interpreted. 
Not only is MRI an indicator of the anatomical dissemination of lesions, it can also 
show new plaques appearing over time; the simultaneous presence of contrast 
enhancing and nonenhancing lesions also suggests dissemination in time (Polman 
CH et al, 2011). At any age, lesions detected in the spinal cord are invariably 
abnormal. Inevitably, diagnostic criteria do not confer absolute protection against 
error, because other diseases can mimic MS.
1.2. PAIN IN MULTIPLE SCLEROSIS
Pain is defined by the International Association for the Study of Pain (IASP) 
as “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” (Merskey H and 
Bogduk N, 1994). The physiological purpose of pain is to protect the individual, 
warning of tissue damage, and most pain resolves rapidly as soon as the painful 
stimulus is removed. However, chronic pain may develop from poorly treated 
acute pain as a result of changes in the function of the CNS: the pain persists and 
has no protective role as it extends beyond the expected period of healing (Turk 
DC and Okifugi A, 2001). Chronic pain has traditionally been determined by an 
arbitrary interval of time since onset; the two most commonly used periods being 
three months and six months from its beginning (Turk DC and Okifugi A, 2001). 
Increasing evidence supports the idea that chronic pain could be understood not 
only as an altered perceptual state, but also as a consequence of maladaptive 
peripheral and central neuronal reorganisation (Baliki MN et al, 2011).
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Early reports stated that pain is an uncommon symptom in MS, and during 
the 90’s decade pain as a symptom was not valued among the constellation of 
clinical problems in this disease (Tourtellotte WW and Baumhefner WW, 1983). 
However, it soon became evident that the majority of MS patients experience pain. 
Three studies obtained prevalence figures between 29% and 65% (Clifford DB and 
Trotter JL, 1984; Stenager E et al, 1991; Vermote R et al, 1986), and pain has 
been recognised as important in the overall health-related quality-of-life (qOL) 
of MS patients (Svendsen KB et al, 2005). Pain severity in MS was identified in 
some studies to be associated with increased disability, female sex, increased 
age, depression, non-stable MS disease course, lower educational level, greater 
duration of pain, and greater health care utilisation (Hadjimichael O et al, 2007). 
Forbes and colleagues found that psychosocial factors were not only strongly 
associated with pain interference but were also more strongly associated with 
pain intensity than demographic and clinical variables (Forbes A et al, 2006). An 
“interdependent relationship” between pain, fatigue and depression in MS patients 
has been described, and other data (Osborne TL et al, 2007) provide support for a 
biopsychosocial model of pain in MS (Kerns R et al, 2002).
Pain syndromes in MS are varied, and may be either nociceptive or 
neuropathic. Pain can be classified as nociceptive when it arises from actual or 
threatened damage to non-neural tissue, and is due to the activation of nociceptors, 
i.e. a sensory receptor that is capable of transducing and encoding noxious 
stimuli. In turn, pain is defined as neuropathic when it is caused by a lesion or 
disease of the somatosensory nervous system, either in its peripheral elements 
(peripheral neuropathic pain) or in the CNS (central neuropathic pain) (www.iasp-
pain.org accessed April 2012). In MS, causality of neuropathic pain may be difficult 
to establish due to temporal and spatial complexity of CNS lesions. MS patients 
seem not to have peripheral neuropathic pain (Osterberg A et al, 2005).
A recent systematic review and classification by O’Connor and co-workers on 
pain associated with MS (O´Connor AB et al, 2008), described several characteristic 
types of pain syndromes related to this disease: central neuropathic pain, painful 
tonic spasms, back pain, and headache.
Central neuropathic pain is considered to be the most common type of pain 
in MS; in a study of 364 MS patients, Osterberg and colleagues found a prevalence 
of 27.5% (Osterberg A et al, 2005). One-third of patients had two or more central 
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neuropathic pain types and locations, and in most, pain affected the lower 
extremities; nearly all patients had sensory abnormalities, with the most common 
being decreased cold sensation (Osterberg A et al, 2005; Vermote R et al, 1986).
It is typically bilateral, affecting legs and feet, usually worse at night and can be 
exacerbated by physical activity (Moulin DE et al, 1988; Osterberg A et al, 2005). 
Because this type of pain often manifests bilaterally in the lower extremities, the 
causative lesion is thought to be in many cases in the spinal cord nociceptive 
pathways (Osterberg A et al, 2005). Other common central neuropathic pain 
conditions are trigeminal neuralgia (TN) and Lhermitte’s sign (O´Connor AB et 
al, 2008). The prevalence of TN in MS patients is believed to be 1-2%, roughly 20 
times the prevalence of TN in the general population (Hooge JP and Redekop WK, 
1995). In patients with TN, the prevalence of MS is also much higher than would be 
expected (Hooge JP and Redekop WK, 1995). In MS patients, 11-31% of TN cases 
are bilateral, and are less likely to have the usual ophthalmic nerve distribution 
(De Simone R et al, 2005).Lhermitte’s sign has been associated with lesions in the 
posterior columns of the cervical spinal cord (Al-Araji AH and Oger J, 2005). The 
prevalence of Lhermitte’s sign in two studies ranged from 9% to 13% (Al-Araji AH 
and Oger J, 2005; Solaro C et al, 2004).
A specific type of episodic muscle spasm associated with MS is called 
painful tonic spasms. Case series indicate that these usually occur several times 
per day, last a few minutes, seem to be stereotypical, and can be triggered by 
touch, movement, hyperventilation, or emotions (Spissu A et al, 1999). MRI lesions 
associated with painful tonic spasms have been shown in the basal ganglia, internal 
capsule, cerebral peduncle, medulla, and spinal cord (Spissu A et al, 1999).
By causing weakness, spasticity, as well as reduced mobility, MS predisposes 
patients to develop secondary nociceptive musculoskeletal pain, in particular in 
the lower back. The prevalence of back pain in MS patients has ranged from 10% 
to 16% (Hadjimichael O et al, 2007; Moulin DE et al, 1988; Osterberg A et al, 2005; 
Solaro C et al, 2004). In some patients back pain was described as being of the 
neuropathic type (Osterberg A et al, 2005; Svendsen KB et al, 2005).
Headache was reported to be more common in patients with MS than in 
the general population. Two studies have found a prevalence of headache in MS 
patients to be 13% (Buchanan RJ et al, 2003) and 12-22% (Hadjimichael O et al, 
2007).
Complex regional pain syndrome (CRPS) (not identified in O’Connor and 
colleagues’ systematic review (O´Connor AB et al, 2008) as a possible pain 
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syndrome in MS), is characterised by pain involving an extremity or other body 
region, hypesthesia (increased sensitivity to cutaneous stimulation), and localised 
autonomic dysfunction following, in the case of MS, a lesion in the CNS. Das 
and Puvanendran reported a case of a patient with MS and CRPS (Das A and 
Puvanendran K, 1999), and Schwartzman and colleagues described a prevalence 
of 2% in a population of 205 MS patients (Schwartzman RJ et al, 2008).
1.3. PAIN, MULTIPLE SCLEROSIS AND NEUROPSYCHIATRIC AND 
NEUROPSYCHOLOGICAL DISTURBANCES
Neuropsychiatric abnormalities in MS can be broadly divided in disorders of 
mood, affect, and cognition. Ghaffar and Feinstein reviewed the neuropsychiatry of 
MS and emphasised depression as the most pressing neuropsychiatric problem 
(Ghaffar O and Feinstein A, 2007). Nearly one in two patients with MS will experience 
clinically significant depression in their lifetime (Minden SL and Schiffer RB, 
1990), a figure three times the prevalence rate in the general population (Kessler 
RC et al, 2003). Rates of depression in MS may exceed those in other chronic 
medical (Patten SB et al, 2005) or neurological illnesses (Dalton EJ and Heinrichs 
RW, 2005). The basic phenomenology of depression in MS was found to overlap 
with that in primary depression (Arnett PA and Randolph JJ, 2006; Moran PJ and 
Mohr DC, 2005). Irritability, frustration and discouragement however, seem to 
be more typical of depression in MS than feelings of guilt and low self-esteem 
(Minden SL et al, 1987). Depression is the most important predictor of suicidal 
ideation in MS (Turner AP et al, 2006). Other described concerns of mood and 
affect, besides depression, are bipolar affective disorder, euphoria, involuntary 
emotional expression disorder (episodes of crying or laughing that are unrelated 
to or out of proportion to the eliciting stimulus) and psychosis (Ghaffar O and 
Feinstein A, 2007).
MS-related cognitive dysfunction is highly prevalent. In neuropsychological 
studies 40-65% of MS patients have shown cognitive impairment (Rao M et al, 
1991). Impaired attention and slowness of information processing are hallmarks 
of subcortical dementia (Beatty WW and Goodkin DE, 1990), and deficits in working 
(Parmenter BA et al, 2006), semantic and episodic (Kenealy PM et al, 2002) 
memory have been reported. Executive dysfunction, including deficits in concept 
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formation, abstract reasoning and verbal fluency were also found (Beatty WW and 
Monson N, 1996; Henry JD and Beatty WW, 2006). MS patients do poorly in the 
Iowa Gambling Task (a psychological task thought to simulate real-life decision-
making), probably reflecting altered decision-making capacity and emotional 
reactivity (Kleeberg J et al, 2004). Their performance may relate to an increased 
sensitivity to immediate reward in addition to an impaired ability to evaluate the 
long-term consequences of decisions (Nagy H et al, 2006).
The definition of pain underlines the fact that psychosocial aspects are not 
additional to the experience of pain, but part of it; these factors influence how 
individuals react to and report pain, and result in coping strategies which may 
be helpful or destructive in maintaining function, particularly in chronic pain. 
Their assessment (and of the specific neurophychological context of the disease 
associated with pain, in this case MS) is thus important.
Catastrophising, a psychological response to pain or anticipation of pain, 
is characterised by rumination, magnification and helplessness, and has been 
associated with impaired functioning and qOL across a variety of chronic pain 
disorders (Edwards RR et al, 2006; Peters ML et al, 2005; Sullivan MJ and Bishop 
SR, 1995). Catastrophising magnifies the possible negative impacts of pain and 
exaggerates helplessness in response to pain; catastrophising was consistently 
associated with greater pain, disability, pain behavior, use of healthcare services 
and longer hospital stays (Sullivan MJ et al, 2001).
In chronic pain patients, preoccupation with or attention to pain is assumed 
to be associated with perceived pain severity (Melzack R and Wall PD, 1982). The 
excessive attention to pain is called hypervigilance, defined as constant scanning 
of the body for somatic and, particularly, pain sensations. Moreover, patients 
reporting more pain vigilance were found to report higher levels of pain intensity, 
emotional distress, psychosocial disability, and more physician visits due to pain 
(McCracken LM et al, 1997).
1.4. MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS AND PAIN
MRI provides an in vivo examination of the human brain. In recent years, 
extensive MRI studies have had a major impact on MS, not only in diagnosis 
(Polman CH et al, 2011), but also in the understanding of the disease. By exploiting 
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the natural history and histopathologic correlations, conventional and novel 
quantitative MRI techniques have demonstrated the ability to image underlying 
pathological processes in MS (Simon JH et al, 2006). Conventional MRI measures 
provide information at the macroscopic level but lack sensitivity and specificity in 
identifying the full extent of underlying MS pathology; they also show relatively weak 
relationships with clinical status (Neema M et al, 2007). Different MRI techniques 
go beyond anatomical imaging and produce a more comprehensive overview of the 
pathophysiological changes that occur in MS (Filippi M et al, 2011). They involve, 
among others, quantitative measures of diffuse damage in normal appearing 
white matter (NAWM) and gray matter on conventional MRI, and functional MRI 
(fMRI) methods, such as the blood oxygenation level dependent (BOLD) technique, 
and non-invasive perfusion imaging. These may present information about the 
extent and nature of brain plasticity which follows MS structural injury, and may 
help to resolve this apparent clinical-MRI paradox. In addition, investigators have 
been using MRI as secondary outcome measure in drug efficacy clinical trials.
Neuroimaging techniques are established methodologies to study pain in 
patients (Schweinhardt P et al, 2006), and MRI in particular to visualise the spatial 
distribution of MS lesions in vivo (Filippi M et al, 2002; Simon JH et al, 2006). 
Structural MRI has been applied to relate clinical symptoms with lesion location 
(Charil A et al, 2003). In the largest series in the literature of MS patients (Osterberg 
A et al, 2005) with well-defined central neuropathic pain who underwent MRI, each 
patient had between five to 16 focal lesions in the brain, with lesions tending to be 
less than 1 cm in size and located in the periventricular white matter; one-third 
of these patients had lesions in the lateral and medial thalamic groups. Because 
such MRI findings are common in patients with MS, the relationship between 
these findings and pain remains to be established (O’Connor AB et al, 2008).
A set of conventional MRI measures is routinely used in MS clinical practice 
and trials. T2-weighted imaging, spin-echo (SE) or fast spin-echo (FSE), is especially 
sensitive in the detection of lesions bellow the tentorium, in the brainstem and the 
cerebellum, but struggles in the detection of lesions in the white-grey matter 
interface of the cerebrum (Bakshi R et al, 2001; Gawne-CainML et al, 1997; Yousry 
TA et al, 1997). The number of plaques observed in the brain (and spinal cord 
scans) of a given patient is expressed by the lesion load. Lesion load correlates 
in several studies with the EDSS (Expanded Disability Status Scale) score, the 
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most commonly used quantitative system for measuring disability in MS (Kurtzke 
JF, 2000; Van Walderveen MA et al, 1998). Although T2-weighted imaging is the 
most commonly used MRI technique, important for MS diagnosis and follow-up, 
additional pulse sequences show different sensitivities in the detection of brain 
lesions depending on their anatomical location. Persistently hypointense lesions 
on T1-weighted images (“black holes”) relate to axonal loss, and show a better 
correlation with clinical disability. Fluid-attenuated inversion recovery (FLAIR) 
imaging provides the highest sensitivity in the detection of lesions close to CSF, 
such as the juxtacortical and the periventricular white matter, but is less sensitive 
in the evaluation of the structures of the cranial posterior fossa (Gawne-Cain ML 
et al, 1997; Yousry TA et al, 1997).
Fukutake and colleagues were one of the few authors that investigated the 
value of spinal cord MRI in studying sensory symptoms in patients with spinal MS. 
They found that magnetic resonance images in the sagittal plane correlated well 
with the levels of sensory impairments, whereas images in the axial plane showed 
a poor relationship to the extent of sensory impairments (Fukutake T et al, 1998).
Recent MS MRI research has been highlighting the need to move beyond the 
lesion-centric view and to develop and validate new imaging strategies that quantify 
the invisible burden of disease and establish more sensitive and specific surrogate 
markers of clinical disability (Filippi M et al, 2011). Several years ago, a double 
inversion recovery (DIR) pulse sequence was introduced (Redpath TW and Smith 
FW, 1994). This sequence attenuates 
the signal of the CSF as well as of the 
white matter, improving the ability of 
MRI to detect cortical lesions (Figure 
2). So far, this sequence has been 
evaluated in only a limited number of 
patients with various disease entities, 
and recovered by Wattjes et al for 
imaging at 3 t in MS patients (Wattjes 
MP et al, 2007).
 
figure 2. Double inversion recovery sequence: both 
the cerebrospinal fluid and the white matter signal 
are attenuated, allowing for better delineation of 
lesions adjacent to the cerebral cortex. Note the 
plaque on the left insular cortex (arrow).
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Water molecule self-diffusion, referring to the microscopic random motion 
in biologic tissues, provides the basis for MRI diffusion-weighted imaging (DWI). 
Images can be produced that demonstrate differences in the magnitude and 
directionality of water diffusion, giving information about tissue integrity at a 
microscopic molecular level (Le Bihan D, 1995). In addition, the data provided, 
using diffusion tensor imaging (DTI), can also serve as the basis for white matter 
fiber tractography, a method to determine the pathways of anatomic white matter 
connectivity. Substantial clinical correlations between DWI findings and clinical 
disability were found in recent studies by using a histogram analysis of global or 
large amounts of tissue (Ciccareli M et al, 2001; Wilson M et al, 2001), but none, to 
our knowledge, has included so far MS patients with pain. Seghier and colleagues 
studied a patient with central poststroke pain attributed to a lesion in the right 
thalamic ventral posterolateral nucleus; DTI maps showed selective reduction of 
right sensory thalamocortical fibers. In another study, Hadjipavlou and co-workers 
(Hadjipavlou G et al, 2006) investigated the white matter connections originating 
from the periaqueductal grey and the nucleus cuneiformis with DTI, two areas of 
the brainstem believed to be important in mediating anti- and pro-nociception 
(Fields HL, 1999). Connections were demonstrated between these nuclei and the 
prefrontal cortex, amygdala, thalamus, hypothalamus and rostroventral medulla 
(Hadjipavlou G et al, 2006).
One of the most promising new measures of the invisible burden of MS (where 
damage of myelin is at the core of the disease pathology) is myelin-selective MRI 
that allows the study of brain white matter myelination. Myelin is composed of 
non-aqueous constituents (lipids and proteins) and water; thus, myelin structure 
can be probed by studying the MRI-visible water component associated with 
myelin. Myelin water was shown to be decreased in MS lesions, as well as diffusely 
reduced in the NAWM when compared to healthy controls (Laule C et al, 2004). 
Myelin water imaging has the potential to quantitatively define the role of myelin 
specific pathology in MS. Laule and colleagues demonstrated a high correlation of 
myelin water fraction (MWF) with myelin density as determined by staining (Luxol 
fast blue) in histhopathological preparations, validating MRI MWF as a measure of 
myelin density (Laule C et al, 2006).
Functional neuroimaging techniques have been invaluable in improving our 
knowledge on brain regions critical for pain processing and our understanding of 
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how cognitive, emotional and contextual factors modulate the pain experience. 
Furthermore, fMRI has helped in investigating key processes in chronic pain 
states, particularly the consequences of chronic pain on the brain’s functioning.
One of the most intriguing recent discoveries concerning brain function is 
that intrinsic neuronal activity manifests as spontaneous fluctuations of the BOLD 
fMRI signal. These fluctuations exhibit temporal synchrony within widely distributed 
brain regions known as resting-state networks (RSNs). It is believed that this 
activity is critical for the development of synaptic connections and maintenance of 
synaptic homeostasis (Pizoli CE et al, 2011). One such network is the default-mode 
network (DMN) that participates in internal modes of cognition, preferentially 
active when the individuals are not focused on the external environment (Raichle 
ME et al, 2001). It includes the medial temporal lobe and the medial prefrontal 
cortex subsystems, converging on important nodes of integration including the 
posterior cingulate cortex (Figure 3), highlighting the possible adaptive role of the 
DMN in planning the future and in social interactions (Buckner RL et al, 2008), 
often impaired, for example, in chronic pain states. Baliki and colleagues (Baliki 
MN et al, 2008), studying with fMRI a group of chronic back pain patients while 
executing a visual attention task, proposed that chronic pain alters the dynamics 
of the DMN. They reported that patients, despite performing the task equally 
well as controls, displayed reduced deactivation in several key DMN regions, 
suggesting that disruptions of the DMN may underlie the cognitive and behavioral 
impairments accompanying chronic pain.
 
figure 3. The default-mode network. Regions belonging to the default-mode network include the medial 
prefrontal cortex, the anterior and posterior cingulate cortex, lateral and inferior parietal cortex, inferior and 
middle temporal gyri and mesial temporal lobe regions, the precuneus, the thalami, and cerebellar areas.
The coordinates refer to mm distances from the anterior commissure and images are shown in radiological 
convention.
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Cerebral perfusion is defined as the volume of blood flowing through a 
unit volume of tissue per unit of time and can be measured by MRI techniques 
that use arterial water as an endogenous tracer – arterial spin labeling (ASL) 
(MacIntosh BJ et al, 2008). Brain perfusion changes have been reported in NAWM 
and in cortical and subcortical grey matter of MS patients (Adhya S et al, 2006). 
Owen and colleagues designed a study to assess if functional activation caused 
by experimental acute painful stimuli could be detected with ASL. The results 
demonstrated that the ASL technique measured changes in the regional CBF in 
brain areas that have been previously associated with pain perception, like the 
secondary somatosensory, insular and cingulate cortices (Owen DG et al, 2008). 
Because ASL directly measures cerebral blood flow (CBF), it may be suited to 
study pain conditions that are difficult to investigate with current fMRI, such as 
chronic pain.
1.5. OBJECTIVES AND STUDY OUTLINE
The pain mechanisms in MS and how pain influences the CNS in this disease, 
already non-resilient, remain poorly understood. Although MRI is one of the 
mainstays in the investigation of MS, and of pain, the study of pain syndromes in 
this disease by neuroimaging remains a developing field. The experimental design 
in this work focused on chronic central neuropathic pain of MS, one of the most 
prevalent, difficult to treat, and incapacitating pain syndromes of this disease. 
More specifically, we aimed at:
1. Characterising the Portuguese reality of pain in MS patients (Chapter 
2.1);
2. Assessing the use of neuroimaging studies in the research of pain in MS 
(Chapter 2.2);
3. Investigating the potential of various functional and structural MRI 
techniques (Chapter 2.3);
4. Studying central chronic neuropathic pain of MS (Chapter 2.4), 
unravelling:
a. etiological pain mechanisms in this disease, through the study of 
lesion topography in the CNS;
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b. the consequences of chronic pain in the brain of MS patients using 
measures of myelin structure, water diffusion, brain volumes and 
perfusion;
5. Investigating resting functional brain changes associated with chronic 
pain in patients with MS, in particular those related to cognition and 
affect (Chapter 2.5).
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Early reports often ignored pain as an important symptom in multiple sclerosis (MS). Pain
prevalence ﬁgures in MS from European countries other than Portugal range between 40
and 65%.To our knowledge there is no published data in English on pain in MS in Portugal.
We describe the demographic and clinical characteristics, with an emphasis on pain, of 85
MS patients followed-up in a Portuguese hospital, contributing to pain epidemiology in MS.
Patients were interviewed sequentially after their regular appointments at the MS clinic;
patients with pain completed The Brief Pain Inventory and The McGill Pain Questionnaire
(MPQ). The prevalence of pain found was 34%. Headache and back pain were the most
common anatomical sites described, followed by upper and lower limbs. Intensity of pain
in an 11-point scale was, for the maximum pain intensity 6.7± 1.8, for the minimum pain
intensity 2.2± 2.0, for the mean pain intensity 4.5± 1.5, and for the actual pain intensity
2.4± 2.9. Pain interfered signiﬁcantly with general activity, mood, work, social relations,
and enjoyment of life. All MS patients with pain employed words from both the sensory
and affective categories of the MPQ to describe it. Patient pain descriptions’ included the
word “hot-burning” in 59% of the cases, common in the report of central pain, but neuro-
pathic pain medications were only used by 10% of them. Pain is an important symptom in
Portuguese patients with MS, not only because of the high prevalence found, concordant
with other European countries, but also because of its interference with quality-of-life.
Keywords: multiple sclerosis, pain, quality-of-life, epidemiology, Europe
INTRODUCTION
Early reports stated that pain was an uncommon symptom in
multiple sclerosis (MS), and during the 1980s it was not valued
among the constellation of MS clinical problems (Tourtellote and
Baumhefner, 1983). However, it soon became evident that many
patients with MS suffer from persistent pain during the course of
their disease. Results from European countries other than Portu-
gal (namely, Italy,Belgium,andDenmark) showed pain prevalence
ﬁgures in MS ranging between 40 and 65% (Vermote et al., 1986;
Stenager et al., 1991; Boneschi et al., 2008), and pain has been rec-
ognized as important in the overall health-related quality-of-life
(QoL) of MS patients (Svendsen et al., 2005). Solaro et al. (2004) in
a cross-sectional study that involved 1672 Italian patients further
explored pain frequencies inMS reporting a prevalence of trigem-
inal neuralgia of 2%, Lhermitte’s sign 9%, dysesthetic pain 18.1%,
back pain 16.4% and painful tonic spasms 11%. In the United
States of America and Canada, pain in MS was reported in 66 and
46% of patients, respectively (Ehde et al., 2006; Piwko et al., 2007).
Pain severity in MS was identiﬁed in some studies to be associated
with female sex, increased age, lower educational level, non-stable
MS disease course, longer duration of pain, depression, increased
disability, and greater health care use (Hadjimichael et al., 2007).
Ultimately, a better knowledge about pain characteristics in MS
will lead to improved care and treatment.
In the 1980s the Iberian Peninsula, comprising Portugal and
Spain, was classiﬁed as a low–medium frequency zone for MS
(Kurtzke, 1980). However, current data has revealed otherwise
(Rosati, 2001), and a recent study has shown a MS prevalence
of 46.3 per 100000 in a region of Portugal (De Sá et al., 2006).
Given the particularities of the disease, all MS patients in Portugal
are followed up in specialized MS clinics managed in the largest
tertiary hospitals. The MS clinic of São João Hospital assists 600
patients per year, 10% of which are newly diagnosed MS cases;
these patients come from the northern part of the country, which
has roughly three million inhabitants.
The objective of this study is to characterize Portuguese MS
patients using two tests of pain measure descriptors, and compar-
ing these results with data fromother countries. To our knowledge,
this is the ﬁrst study that has examined pain in Portuguese MS
patients.
MATERIALS AND METHODS
Eighty-ﬁve patients from the universe of patients of the MS clinic
of São João Hospital, Porto, Portugal, participated in the study.
To be included, the patients had to be more than 18 years old and
have a deﬁnitive diagnosis of MS according to the revisedMcDon-
ald criteria (Polman et al., 2005). Exclusion criterion was serious
cognitive impairment. Patients in follow-up at the clinic were
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identiﬁed and recruited consecutively during the period of 1 year
(2007), after their regular appointments. Eight patients declined to
enter the study (not willing to participate), and four subjects were
excluded based on the study criterion. The project was approved
by the São João Hospital Ethics Committee; informed consent was
obtained from all subjects.
The clinical records of each patient were consulted to obtain
data on age, gender, education level, race/ethnicity, disease dura-
tion, year of diagnosis, MS type (explained ahead), treatments,
and the presence of pain. The course of MS develops broadly
into four disease types: relapsing–remitting, secondary progres-
sive, progressive-relapsing, and primary progressive. The clinical
evolution of MS usually occurs in relapses in the ﬁrst years of
the disease, with remission of the symptoms and signs (relapsing–
remitting), and then becoming progressive with time (secondary
progressive MS). Other subtypes of the disease, more aggressive,
are progressive-relapsing MS (the signs and symptoms of the dis-
ease do not abate completely after each relapse), and primary
progressive MS that lacks the characteristic episodic evolution,
being progressive from the onset. Additionally, the ﬁrst sympto-
matic form of the disease is the denominated clinically isolated
syndrome.
For eachpatient the score of theExpandedDisability Status Scale
(EDSS; Kurtzke, 1983) was determined by a neurologist on the day
of the study session. The short version of the pain questionnaires
The Brief Pain Inventory (BPI; Daut et al., 1983) and The McGill
Pain Questionnaire (MPQ; Melzack, 1987) were administered to
patients who reported pain during the week previous to the study
session.
EXPANDED DISABILITY STATUS SCALE
The EDSS is a method of quantifying disability in MS. The score
is based on neurological testing of eight functional systems: pyra-
midal, cerebellar, brainstem, sensory, bowel and bladder, visual,
mental, and other (Kurtzke, 1983). The EDSS has a possible range
from 0, indicating no disability and normal neurological examina-
tion, to 10, referring to death due to MS. EDSS steps 1.0–3.5 refer
to patients with MS that are fully ambulatory; EDSS steps 4.0–9.5
are deﬁned by the impairment to ambulation. In the present study
EDSS scores were categorized as mild (0–3.5),moderate (4.0–6.0),
and severe (6.5–9.5).
SHORT VERSION OF THE BRIEF PAIN INVENTORY
TheBPIwas developed to evaluate the intensity and impact of pain
in the daily functioning of patients. Osborne et al. (2006) evalu-
ated the psychometric properties of the short version of the BPI in
patients withMS and pain, and concluded that results support the
validity of the modiﬁed versions of the original long form of the
BPI. The short version of the BPI consists of a diagram to record
pain location in a human ﬁgure and scales for pain intensity and
impact evaluation. Pain intensity is registered in numerical scales
that vary from zero (“no pain”) to 10 (“the worst pain possible”).
Impact of pain is measured in relation to how the pain interferes
with general activity, mood, walking ability, work, social relations,
sleep, and enjoyment of life in 11-point scales (“no interference”
to “interferes completely”). Patients are asked as well about their
pain treatment and relief obtained with it.
SHORT VERSION OF THE McGill PAIN QUESTIONNAIRE
The short version of theMPQ evaluates pain dimensions notmea-
sured in BPI by estimating the sensory and affective elements
of pain, both qualitatively and quantitatively (Melzack, 1987).
It consists of 15 words, 11 representing the sensory category of
pain and four representing the affective category of pain, taken
from the long version of the MPQ. Detailed description of the
long version of the MPQ was reported elsewhere (Melzack, 2005).
Pain intensity is classiﬁed for each word contained in the short
version of the MPQ (see Table 3 for a list of words) using a four-
point scale (0=“no pain”, 1=“mild pain”, 2=“moderate pain”,
3=“high pain”). Two scores are obtained from the sum of the
sensory and the affective ratings; the total score is obtained adding
the sensory and affective scores. The short version of the MPQ
also includes a measure for current pain intensity score, which is a
six-point scale from 0=“no pain”, 1=“mild”, 2=“discomforting”,
3=“distressing”, 4=“horrible” to 5=“excruciating”, and a visual
analogue scale.
STATISTICAL ANALYSIS
There was no missing data. Distributions by frequency were gen-
erated for every categorical variable for the descriptive aspects
of the analysis. For homogenous variances, the t test of Student
was used to compare two patient groups (pain and no pain). For
non-homogenous variances, theMann–Whitney test was adopted.
The Chi-square test was used for comparisons between categorical
variables. Relationships between age, disease duration, neuro-
logic symptom severity (EDSS) and pain intensity were assessed
using Spearman or Pearson correlation coefﬁcients as appropri-
ate. Statistical signiﬁcance was considered for p values inferior
to 0.05. Statistical analyses were performed using SPSS (SPSS
software INC) and results are presented as mean respectively
median± SD.
RESULTS
The demographical characteristics of the MS patient sample
(Table 1) shows that most of the patients were young adults, pre-
dominantly females. The education level was low, and the authors
noted reading literacy problems during the questionnaires’ ﬁlling
by the patients.
Considering the clinical characteristics of the patient sample
(Table 2), median EDSS score was 2. The majority of patients suf-
fered from the relapsing–remitting subtype of the disease, and the
overall distribution of disease characteristics’ was similar to that
described for other EuropeanMS patient populations (Alonso and
Hernán, 2008). Eleven percent of the cases were clinically isolated
syndromes, with clinical, laboratorial, and magnetic resonance
imaging results that allowed for MS diagnosis.
Twenty-nine patients of a total of 85 (34%) had pain in the
day and/or the week previous to the study session. Six patients
(2%) reported pain in more than one location. Comparing the
group of MS patients with pain with the group of MS patients
without pain, no difference was found pertaining gender (Chi-
square, p= 0.672), mean age (t test, p= 0.371), EDSS score by
categories (Chi-square, p= 0.995), mean duration of the disease
(in years; Mann–Whitney, p= 0.771), use of disease-modifying
therapy (Chi-square,p= 0.680),ormean education in years (t test,
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Table 1 | Demographic characteristics of the MS patient sample.
Mean (SD, min, max)
Age 39.7 (11.7, 18, 64)
Number of patients (%)
Gender
Male 23 (27)
Female 62 (73)
Education level
4 years or less 22 (26)
6 years 14 (17)
9 years 9 (11)
12 years 23 (27)
More than 12 years 17 (20)
Race/ethnicity
Caucasian 85 (100)
Marital status
Married or living as married 54 (63)
Single 21 (25)
Divorced 9 (11)
Widowed 1 (1)
Table 2 | Clinical characteristics of the MS patient sample.
Mean (SD)
Disease duration in years 10.9 (7.1)
Years since the diagnosis 11.3 (9.7)
Median
EDSS score 2
Number of patients (%)
MS type
Relapsing-remitting 60 (71)
Secondary progressive 15 (18)
Primary progressive 1 (1)
Clinically isolated syndrome 9 (11)
Table 3 | Qualitative pain characteristics: list of words representative
of the sensory and affective dimensions of the short version ofThe
McGill Pain Questionnaire, and percentage of MS patients with pain
that used each word.
Sensory dimension Affective dimension
(% of patients) (% of patients)
Throbbing (0) Tiring-exhausting (94.1)
Shooting (47.1) Sickening (85.4)
Stabbing (70.6) Fearful (52.9)
Sharp (64.7) Cruel-punishing (23.5)
Cramping (0)
Gnawing (41.2)
Hot-burning (58.8)
Aching (64.7)
Heavy (94.1)
Tender (47.1)
Splitting (41.2)
p= 0.241). Age, disease duration or neurologic symptom sever-
ity (EDSS) were not signiﬁcantly correlated with pain intensity
(r = 0.218, r = 0.321, r = 0.092, p> 0.05, respectively).
Twenty-one patients (72%), of the total of 29 patients with
pain in our study, completed the short versions of the pain ques-
tionnaires BPI and MPQ. Considering the results of the BPI on
pain localization, shown in Figure 1, headache and back pain
were the most common anatomical sites described (27%), fol-
lowed by upper (20%) and lower limbs (13%). Experienced pain
was more often superﬁcial (86%) as opposed to deep (14%). Per-
taining to intensity of pain in an 11-point scale (Figure 2), it
was, for the maximum pain intensity 6.7± 1.8, for the minimum
pain intensity 2.2± 2.0, for the mean pain intensity 4.5± 1.5 and
for the actual pain intensity 2.4± 2.9. Sixty-two percent of the
patients were taking pain medications – with a mean relief of 75%
(±28) – and 10% were being treated with drugs for neuropathic
pain (gabapentin, amytriptiline, carbamazepine). The remainder
were being treated with analgesics (paracetamol, caffeine) and/or
non-steroidal anti-inﬂammatory drugs. Interference of pain (in a
scale from 0 to 10 points) with general activity was 6.3± 4.1, with
FIGURE 1 | Pain localization. Data obtained from the short version of the
Brief Pain Inventory.
FIGURE 2 | Pain intensity in an 11-point scale of the Brief Pain
Inventory (0=“no pain” e 10=“the worst pain possible”).The
horizontal line deﬁnes the median point of the scale (5).
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FIGURE 3 | Pain interference with general activity, mood, walking
ability, work, social relations, sleep, and enjoyment of life in an
11-point scale of the Brief Pain Inventory (0=“no interference” e
10=“interferes completely”).The horizontal line deﬁnes the median point
of the scale (5).
mood was 7.2± 2.8, with walking was 4.5± 3.8, with work was
6.3± 3.6, with relations with others was 5.1± 4.2, with sleep was
4.6± 3.8 and with enjoyment of life was 7.2± 3.2 (Figure 3).
The patients’ subjective descriptions of their pain using the
words from the short version of the MPQ are detailed in Table 3.
The sensory and affective scores of the MPQ were, respectively,
12.1 and 6.2; the total score was 22.3. Actual pain intensity in a
six-point scale was 1.6± 0.4. All the patients used more than one
word to describe their pain, and always used words from both
categories, sensory and affective. The words most frequently used
were“heavy”and“tiring-exhausting” in 91.4% of the patients, and
“hot-burning” in 58.8% of the cases.
DISCUSSION
The prevalence of pain found in this study, 34%, is in accordance
with the range of results from other European countries (Clif-
ford and Trotter, 1984; Vermote et al., 1986; Stenager et al., 1991).
However, there is some variability that might be related to differ-
ences/heterogeneity between the studied populations, and/or vari-
ation in the methodologies used. For example, studies differ in the
sources from which the samples were drawn (e.g., hospital, ward,
clinic, community, MS organizations) as well as in the sampling
methodologies used (e.g., random, convenience). In our study,
pain characterization by the patients was done reporting to pain
experienced in the week previous to the study session, avoiding
memory and other cognitive biases and/or symptom ﬂuctuation
that could interfere with the results. Headache was included in
the evaluation of pain location (which was not reported in other
studies; Clifford and Trotter, 1984; Stenager et al., 1991), because
there is evidence that it may be secondary to MS disease processes
(Archibald et al., 1994). However, including patients that reported
pain in the week before the study visit may have, on the other
hand, introduced a bias on the prevalence of episodic pains like
headache. The MS diagnostic criteria used in the present study,
from the International Panel on the Diagnosis of Multiple Sclero-
sis of 2001, and revised in 2005 (Polman et al., 2005), may have
also had an impact in our results, especially when compared with
older studies, because the actual criteria have more sensitivity and
speciﬁcity, and allow earlier disease diagnosis (Poser et al., 1983;
CHAMPS Study Group, 2002; Dalton et al., 2002). In this way,
we strongly believe patients with other diseases besides MS were
excluded, a possible confounder of the prevalence ﬁgures.
The ﬁnding that the head, back, and upper limbs were the most
common pain sites in our Portuguese MS population is consis-
tent with other studies (Ehde et al., 2006). Similarly to Ehde et al.
(2006) and Stenager et al.’s (1991) results, we have not found an
association neither between pain intensity and MS duration (as
measured by the time since the beginning of the symptoms, and
not by the time since initial diagnosis) nor between pain intensity
and functional impairment (EDSS score). Results in the literature
are dissimilar, maybe reﬂecting once more methodological issues
or population discrepancies. The dissimilarity may additionally
reﬂect heterogeneity of pain mechanisms in MS: it is known that
just one lesion in a key area of the central nervous system can cause
a neuropathic pain syndrome, implying that this type of pain can
appear at any stage of MS. On the other hand, the higher the func-
tional impairment during disease progression, the more likely is
pain from the nociceptive type to appear, secondary for exam-
ple to spasticity and mobility problems,making these associations
difﬁcult, and probably even not useful to make.
Regarding BPI results, only 10% of the patients were taking
drugs for neuropathic pain treatment for pain relief. On the other
hand, patient pain descriptions’ from the MPQ included the word
“hot-burning” in 58.8% of the cases, a word commonly used in
the report of central pain. Considering these results and the fact
that neuropathic pain is referred in the literature as the most com-
mon pain syndrome in MS (Fischer et al., 1999; Osterberg et al.,
2005), our patients are probably being undertreated for their pain
syndromes.
Pain interferedmeaningfully with general activity,mood,work,
relations with others, and enjoyment of life, that is, ﬁve of the
seven parameters used in the QoL assessment. According to Daut
et al. (1983), pain intensity or interference in QoL can be con-
sidered meaningful above the median point 5 of the BPI scales. In
view of this,maximumpain intensity wasmeaningful in our study
(Figure 2), as well as pain interference with general activity,mood,
work, relations with others, and enjoyment of life (Figure 3). To
our knowledge, only in a study by Ehde et al. (2006) was the BPI
used as a pain and QoL measure in MS patients. The average level
of overall pain interference with QoL was signiﬁcantly higher in
our study (t test, p< 0.001), further supporting the idea that pain
has a major impact in the QoL of our Portuguese sample of MS
patients.
Pain revealed to be an important symptom in this sample of
85 MS patients, not just for the reason of the high prevalence
found – in line with results from other European countries – but
also because of the major interference of pain with the QoL of
these patients. Given that the majority of patients were young
adults and had a low education level and literacy [corroborated
by the Organization for Economic Co-operation and Development
(OECD); www.oecd.org/dataoecd/44/35/14735458.pdf, accessed
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in June 6, 2009], this may have consequences in an individual
perspective,possiblymaking itmore difﬁcult for patients to under-
standMSdiagnosis, prognosis, impact in daily life, andmedication
regimes, and, consequently, reducing compliance. In light of our
results, we believe that an extra effort should be made to better
identify MS patients with clinically meaningful pain syndromes in
order to properly manage and treat these patients attenuating the
devastating consequences of chronic pain.
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Abstract
Background:  While pain in MS is prevalent, its mechanisms remain poorly understood. Neuroimaging is important 
in the investigation of MS, and pain. Objective and Methods:  Summarise the literature on neuroimaging in 
MS pain. Results: We retrieved 34 studies, mostly aimed at reporting a neuroradiological association with 
neuropathic pain. There was a bias towards headache/facial pain; the most frequent lesion location responsible 
was the brainstem. The neuroimaging method used was mostly MRI, with no functional or molecular studies. 
Conclusion: Literature is scarce and poor in the field; this review should provide a basis for the design and 
interpretation of future studies.
Key words
Pain, multiple sclerosis, magnetic resonance imaging, positron-emission tomography, single-photon emission-
computed tomography
Introduction
Neuroimaging in general, and magnetic resonance 
imaging (MRI) in particular, is a powerful, and 
widely used, method in the study of the human 
central nervous system (CNS) structure and function. 
Modern neuroimaging is relatively safe, and rapidly 
evolving techniques now allow in vivo visualisation of 
detailed neuroanatomy of the brain and its pathology, 
including, for example, white matter tracts, myelin, 
and brain activity and perfusion.
Multiple sclerosis (MS) is an inflammatory disease 
of the CNS associated with demyelination and 
neurodegeneration. It has a broad spectrum of 
neurological signs and symptoms that in the majority 
of patients are initially relapsing-remitting (RR), 
although subsequently the disease usually follows a 
progressive course (1). MRI is crucial in the diagnosis 
of MS (2) as well as in research applications, and is 
able to demonstrate the distribution of inflammatory 
lesions and non-lesional tissue changes (3).
Pain has been recognised as a symptom of MS since 
the first descriptions of the disease (4), although most 
of the published evidence is recent. It is a common 
symptom, with estimates of prevalence ranging up to 
85% (5), and may broadly be classified as nociceptive 
or neuropathic (6). Patients with MS often rank pain 
as one of their most distressing symptoms (7), and the 
appreciable burden placed on individuals suffering 
with MS is closely linked to disability (8). However, in 
spite of the prevalence and clinical importance of pain 
in MS, the mechanisms of pain in this disease remain 
poorly understood.
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MRI of the CNS has proved a useful tool in pain 
research in general, and it is likely to have an even 
more relevant role in the clinical setting potentially 
including drug development in addition to diagnostic 
applications (9). Positron-emission tomography (PET) 
and single-photon emission-computed tomography 
(SPECT), although have lower spatial resolution 
than MRI, have been invaluable in the study of 
neurotransmitter systems involved in pain, including 
opioid and dopamine receptors.
While neuroimaging is now one of the mainstays in 
the investigation of MS, and of pain, the study of pain 
syndromes in this disease by neuroimaging remains 
an undeveloped field. This review summarises the 
literature on neuroimaging in MS pain (by MRI, PET 
or SPECT) to date, and should provide a basis for the 
design and interpretation of future studies.
Materials and Methods
Search strategy
PubMed® and Scopus® were searched for articles 
published in English language, limited to human 
studies, from their inception dates (1977 and 1960, 
respectively), up to the 28th November 2011.
The keywords used for the PubMed® search included 
the medical subject heading (MeSH) terms “pain” and 
“multiple sclerosis” along with “magnetic resonance 
imaging” or “positron-emission tomography” or 
“tomography, emission-computed, single-photon”. 
The keywords used for the Scopus® search included 
all the entry terms of each of the MeSH terms of 
PubMed® and the MeSH terms themselves, combined 
in the same manner.
Inclusion and exclusion criteria
All original articles in English language studying 
neuroimaging correlates of pain in MS – using MRI, 
PET or SPECT imaging – in human adults were 
eligible for inclusion. Articles studying paediatric 
populations, review articles, and those studying 
diseases other than MS (for instance neuromyelitis 
optica) were excluded from analysis.
Selection of included studies
The titles and abstracts of retrieved citations 
were reviewed and prioritised by relative content. 
Duplicates were eliminated. Full articles were then 
obtained, and reviewed independently by two authors 
(D.S. and P.F.). References were hand-searched 
for additional material where appropriate. For the 
purposes of descriptive analysis, case studies, case 
series, and original articles were considered separately. 
Descriptive statistical analysis was conducted.
Quality assessment
Original article quality was assessed by considering 
explicit description of the following 11 components 
(adapted from Campbell and colleagues (10)): having 
a clear research objective; describing the recruitment 
procedure, the inclusion/exclusion criteria, the 
population parameters/demographics, the participation 
rates, the pain measures, and the imaging protocol; 
reporting strength of effect and a participation 
rate above 70%; using multivariate analysis; and 
acknowledging the limitations of the research. Taking 
into account the low number of studies in the field, 
no studies were excluded from review on the basis of 
quality assessment.
Results
The search using the databases Scopus® and PubMed®
yielded a total of 560 publications (see Figure 1 for a 
flow diagram of the review procedure). Four hundred 
and ninety one publications were retrieved in Scopus®
with reference to the study of pain in MS with MRI, 
25 publications with PET and four with SPECT. In 
PubMed® 40 publications were obtained concerning 
the study of pain in MS with MRI, and none with 
PET or SPECT. Five hundred and three articles were 
excluded at the title and abstract screening stage, 
Figure 1. Flow diagram of the review procedure.
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with a further 32 articles excluded using full text screening. A further 
nine articles were included via additional search strategies (hand search, 
expert consultation, citation search). This resulted in 34 articles eligible 
for inclusion in the review (11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 
32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44).
Of the total of 34 papers, 13 were case reports (11, 14, 16, 17, 21, 27, 28, 31, 32, 37, 40, 
42, 43), nine were case series (12, 18, 22, 24, 29, 33, 34, 35, 36), and 12 were original 
articles (13, 15, 19, 20, 23, 25, 26, 30, 38, 39, 41, 44). The number of cases described in 
each case series were: two (24), three (22), four ((29) – four cases reported 
but only two of the patients were studied with neuroimaging, (35)), five 
(12, 18, 33, 36), and seven ((34) – although seven cases were reported, only 
one had a pain syndrome). Characteristics of the 12 included original 
studies (including type of study, study population, main study focus, 
pain assessment, imaging and main findings) are detailed in Table 1.
Quality assessment of original articles
Methodology of the included original studies (n=12) was assessed using 
the 11-item quality criteria specified above. The mean number of criteria 
fulfilled was 5.7 (SE 0.7) (median 5, minimum 3, maximum 11); Kister 
et al was the only article that fulfilled all the criteria (30), and nine papers, 
i.e. 75%, fulfilled half of the criteria (details in Table 2).
Diagnosis of multiple sclerosis
The criteria used for the diagnosis of MS was stated in 14 of the total of 
34 papers. From the most recent to the older criteria, four papers (19, 24, 27, 
30) used revised McDonald criteria (45), six (13, 17; 20, 26, 29, 44) used McDonald 
criteria (46), four (15, 29, 31, 34) used Poser criteria (47), and one paper (38) used 
Rose et al criteria (48).
Balasa 2010 YES YES NO NO NO YES NO NO NO NO NO
Broggi 2004 YES YES NO YES NO YES YES NO NO NO NO
Cruccu 2009 NO YES YES YES YES YES NO NO NO YES NO
Eldridge 2003 YES YES NO YES NO NO YES NO NO NO NO
Gass 1997 YES YES NO YES NO NO YES NO NO NO NO
Gee 2005 YES YES YES YES YES YES NO YES YES YES NO
Kister 2010 YES YES YES YES YES YES YES YES YES YES YES
Ramirez-Lassepas 1992 NO YES NO YES NO NO NO NO NO YES NO
Da Silva 2005 YES YES NO YES NO NO YES NO NO YES NO
Svendsen 2011 YES YES YES YES YES YES YES NO NO NO NO
Tortorella 2006 YES YES YES YES NO YES YES NO NO YES NO
Yetilamar 2008 YES YES NO YES NO NO YES NO NO NO NO
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Quality assessment criteria 
Original studies
Table 2. Quality criteria met by each of the original studies included in the 
review
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Reference to the subtype of MS in the patient sample 
was not made in 12 articles ((12, 13, 16, 19, 23, 24, 30, 33, 34, 38, 
44); (35) – unknown in three of the patients, out of four 
patients in total). Of 18 papers describing the subtype 
of MS, it was RR in 15 articles ((11, 14, 17, 22, 27, 28, 29, 31, 32, 36, 
37, 40, 42); (35) – one case), progressive in two papers ((18)
– in two cases primary-progressive and in three cases 
secondary-progressive; (21) – secondary progressive), 
and progressive-relapsing in one publication (43). Six 
papers included patients with various MS subtypes (15,
20, 25, 26, 39, 41).
Imaging methodology
The neuroimaging method used in all the articles was 
structural MRI. There were no articles using functional 
magnetic resonance imaging, other “advanced” MRI 
modalities. MRI field strength was not specified in 21 
articles (11, 12, 14, 16, 17, 18, 19, 21, 22, 24, 27, 28, 29, 31, 32, 33, 35, 38, 40, 42, 43).
One tesla (T) scanners were used in two of the papers 
(13, 20), and 1.5 T scanners were used in nine papers ((23,
25, 34, 36, 37, 39, 41, 44), (26) – not clear if other field strengths 
were also used). Scanners of various strengths were 
employed in two articles (0.6 T, 1.5 T and 3 T (30), and 
0.5 T and 1.5 T (15)).
MRI protocols were not stated in 67.6% (n=23) of 
the articles ((11, 13, 14, 16, 17, 18, 21, 22, 24, 27, 29, 31, 32, 33, 35, 36, 37, 
38, 40, 42, 43), (19, 26) – used a dedicated protocol); 17.4% 
(n=4) were original papers and 82.6% (n=19) were 
case reports/series. The MRI protocol was detailed 
or partially detailed in 32.4% (n=11) of the articles
MRI image acquisition Papers
Scanner Meaney 1995; Svendsen 2011; 
Gass 1997; Eldridge 2003
Field strength Meaney 1995; Svendsen 2011; 
Gass 1997; Eldridge 2003; Kister 
2010; Tortorella 2006; Broggi 
2004; da Silva 2005; Yetimalar 
2008
Sequences
All the sequences used
Some of the sequences 
used
Haas 1993; Meaney 1995; Kister 
2010; Tortorella 2006; Svendsen 
2001; Broggi 2004; da Silva 2005; 
Gass 1997
Athanasiou 2005; Eldridge 2003
Sequence parameters
All the sequences used and 
all its parameters
Some of the sequences 
used and/or some of the 
parameters
Tortorella 2006; Svendsen 2011; 
da Silva 2005; Gass 1997
Haas 1993; Meaney 1995; Broggi 
2004; Athanasiou 2005
Table 3. Descriptions of MRI methodology
(12, 15, 20, 23, 25, 28, 30, 34, 39, 41, 44), and of these 72.7% (n=8) 
were original papers. Details of the description of 
the MRI protocols are given in Table 3. From the 
articles describing the MRI protocol used, 36.4% 
described the scanner, 81.8% mentioned the field 
strength, 90.9% described the type of sequences used 
(80% described all of them), and 72.7% described 
the sequence parameters (50% described all of the 
sequence parameters of all the sequences used). The 
reading method of the images was mentioned in five 
of the 12 original articles (41.7%).
Pain syndromes
In all articles neuropathic pain was studied. There were 
no studies investigating nociceptive or psychogenic 
pain. Pain was the presenting MS symptom in 22.7% 
of the case reports/series. The different pain syndromes 
studied are summarised in Table 4. Most of the papers 
(76.5%, n=26) focused on headache disorders, and 
the remainder on bodily pain (17.6%, n=6), except 
for two original articles (5.9%), which included both 
patients with headache/facial pain and body pain 
in their patient samples (39, 44). The classification of 
headache disorders used was not specified in four of 
the 10 original articles studying headaches (15, 20, 23, 
25), and in the remainder (n=6) the criteria used were 
those of the International Headache Society 1988 (49)
or 2004 (50) ((26) – 1988 criteria, (13, 19, 30, 41, 44) – 2004 
criteria).
In only one paper (19), an electrophysiological technique 
(recording of trigeminal reflexes) complemented 
neuroimaging methods in the study of pain.
Lesion localisation
The localisation of a MS lesion possibly responsible 
for the different neuropathic pain syndromes was 
discussed in all case reports/series (Table 5), although 
in four studies (12, 17, 21, 35) a lesion in the expected 
location was not found. The majority of authors 
assigned probable culprit lesions on the basis of 
plausible anatomical location, though some studies 
also demonstrated a temporal correlation in lesion 
appearance or resolution by the use of serial imaging. 
Some studies also studied time course of MS plaques 
by use of contrast (see Table 5).
Lesion topography was in the CNS (i.e. central 
neuropathic pain) in 17 articles; of these, lesions were 
located in the spinal cord in six papers ((11, 16, 42), (22) 
– three cases, (29) – four cases: only two documented 
with MRI, (33) – five cases), and in the brainstem in 
11 articles ((14, 27, 28, 31, 32, 40), (34, 36, 43) – one case, (24) – two 
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Type of pain syndrome Study
Headache disorders
Migraine Fragoso 2007; Kister 2010; 
Tortorella 2006
Cluster headache and 
other trigeminal autonomic 
cephalalgias
Cluster headache – Gentile 
2007
Cluster-like headache – Lean-
dri 1999
SUNCT – Davey 2004; Vilisaar 
2006
Probable trigeminal autonomic 
cephalalgia with allodynia – Liu 
2008
Cranial neuralgias and cen-
tral causes of facial pain
Glossopharyngeal neuralgia 
– Carrieri 2009; Minagar 2000
Occipital neuralgia – de Santi 
2009 (2 cases)
Painful third nerve palsy 
– Bentley 2002
Transverse colli neuralgia – de 
Santi 2009 (1 case)
Trigeminal neuralgia – Meaney 
1995; Nakashima 2001; 
Cordella 2009; Athanasiou 
2005; Pichiecchio 2007; Balasa 
2010; Cruccu 2009; Broggi 
2004; da Silva 2005; Gass 1997; 
Eldridge 2003
Other headache, cranial 
neuralgia, central or primary 
facial pain
Atypical trigeminal neuralgia/
facial pain – Tanei 2010
Headache – Alstadhaug 2007; 
Haas 1993
Body pain
Pseudo-radicular pain Cervical – Tosi 1998
Sciatica – Marchettini 2006
Various levels – Ramirez-
Lassepas 1992
Dysesthetic pain Burkey 2010; Hellwig 2006
Pain and painful itching Hellwig 2006
Visceral pain Marchettini 2006
Various Svendsen 2011; Yetimalar 2008
SUNCT – short-lasting unilateral neuralgiform headache with conjuncti-
val injection and tearing
Table 4. Types of pain syndromes studied.
cases, (18) – five cases). All the cases of brainstem 
lesions corresponded to headache disorders; the spinal 
cord lesions corresponded either to headache disorders 
(33.3%) or to body pain (66.7%) (Table 5). Lesions 
including both the central and peripheral nervous 
systems were described in one study (brainstem and 
trigeminal nerve – (37)).
Six studies found coexistent lesions not related to 
MS but felt to explain neuropathic pain syndromes: 
neurovascular contacts in the case of trigeminal 
neuralgia (TN) (12, 23, 34), epidermoid tumour (34),
degenerative spinal disease (33), and urethral 
malformation (33).
Treatment of pain
In seven of the articles (20.6%), although 
neuroimaging was used to study pain syndromes in 
MS, the main focus of the paper was an invasive pain 
treatment. Three papers addressed microvascular 
decompression for TN (12, 15, 23), three other papers 
concerned CNS stimulation (motor cortex stimulation 
– (40), spinal cord stimulation – (16), posterior nucleus 
of the hypothalamus stimulation – (18)), and one article 
referred to intrathecal application of triamcinolone 
acetonide (29).
Discussion
Our review demonstrates that studies investigating 
pain in MS with neuroimaging methods are scarce. 
In addition, the majority take the form of case 
reports/series aimed at reporting an interesting 
neuroradiological association with a pain syndrome. 
Although such studies are of value in detecting or 
describing novel cases and associations, they are less 
rigorous than controlled data, and their implications 
for clinical practice and research are limited (51).
We identified only 12 original articles, and assessed 
methodological quality using the criteria discussed 
above. Of the identified studies, only 25% met at least 
half of the quality criteria used in this review, and 
only one paper met all the criteria (30). In particular, 
very few studies explicitly discussed strength of effect 
(n=2), used multivariate analysis (n=2), or reported a 
patient participation rate over 70% (n=1) (see Table 
2). Our quality assessment therefore suggests that 
conclusions drawn from the individual studies should 
be treated with caution and, as well, attempts to draw 
inferences from the data presented as a whole, are 
limited.
All of the publications retrieved, focused on 
neuropathic pain (pain caused by a lesion or disease 
of the somatosensory nervous system) (52), despite 
frequent observations in cross-sectional studies that 
in MS nociceptive pain (pain that arises from actual or 
threatened damage to non-neural tissue and is due to 
the activation of nociceptors) (52) is prevalent and may 
also coexist with neuropathic pain (53).
There was a bias towards reporting of investigation of 
headache disorders and facial pain in MS (76.5% of 
the total of papers), in particular TN (11 articles). This 
emphasis is at variance with estimates of prevalence of 
pain syndromes in MS. For example, TN is reported 
in approximately 4-6% of MS patients (54, 55), as 
compared to an overall pain prevalence of up to 85% 
in MS (5). Other studied headache syndromes including 
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Study Pain syndrome or loca-
tion
Localisation of the lesions possibly 
explaining the pain syndrome
Basis of asso-
ciation
(A/
Spinal cord
Tosi 1998 Radicular Cervical (C5-C6) dorsal root entry zone and posterior horn A, S
Alstadhaug 2007 Headache (type not defined) Posterior part of the upper cervical spinal cord A, S
Burkey 2010 Upper limb pain Posterior columns from C2 to C4 A
Hellwig 2006 Painful dysaesthesia at tho-
racic level and/or below
Posterior upper thoracic spinal cord; cord lesions at the level 
of C1, C4/5, Th3 (two cases)
A, C
De Santi 2009 Occipital neuralgia Right antero-lateral spinal cord at C2; C1, C2, C3 and D1-D2; 
C2-C3 lesion (three cases)
A, S, C
Marchettini 2006 Back, leg, flank or abdominal 
pain
Spinal cord location of the lesions assumed; MRI was used 
to exclude other causes of pseudo-radicular or visceral pain 
(five cases)
n/a
Brain
Bentley 2002 Painful third nerve palsy 
(including pupil)
Midbrain adjacent to right third nerve fascicle A, S
Tanei 2010 Facial pain (non-TN) Right dorsal pons and medulla oblongata A
Haas 1993 Headache (type not defined) Periaqueductal grey A, S, C
Liu 2008 Probable TAC with allodynia 
and other symptoms
Right lateral tegmentum of the lower pons A, S
Leandri 1999 TAC Root entry zone of the trigeminal nerve on the right A
Gentile 2007 Cluster headache/TAC with 
sensory symptoms
Left brachium pontis A, S
Meaney 1995 TN (unilateral or bilateral) Root entry zone of both trigeminal nerves (one case out of 
seven cases described)
A
Nakashima 2001 TN Left trigeminal root entry zone (one case out of five cases 
described)
A
Fragoso 2007 Migraine without aura Brainstem (two cases) A
Cordella 2009 TN Trigeminal root entry zone (five cases) A
Pichiecchio
2007
TN Trigeminal root entry zone bilaterally and enhancement of 
trigeminal nerves
A/C
Vilisaar 2006 SUNCT Anterior pons, right cerebral peduncle and medulla (one case) A
A – anatomically plausible lesion; S – serial imaging demonstrating emergence or disappearance of plaque in line with clinical pain syndrome; C – con-
trast enhancing plaque; n/a = not applicable; TN – trigeminal neuralgia; TAC – trigeminal autonomic cephalalgia; SUNCT – short-lasting unilateral 
neuralgiform headache with conjunctival injection and tearing; MRI – magnetic resonance imaging
Table 5. Location of candidate culprit multiple sclerosis lesions in the origin of pain as detected by magnetic resonance 
imaging in the case reports/series retrieved.
short-lasting unilateral neuralgiform headache with 
conjunctival injection and tearing, along with the 
cranial pain syndromes occipital and glossopharyngeal 
neuralgia (17, 21, 22, 35, 43) are even less common than TN. 
Only three of the studies retrieved did not describe 
a positive association with an abnormality detected 
on MRI, and on the other hand, it is relatively easy 
to attribute a causal lesion to TN, for example. It is 
reasonable to hypothesise, therefore, that lack of positive 
associated neuroradiological findings in investigation 
of an MS-related pain syndrome may have exerted an 
influence, perhaps, at the level of both selection and 
publication bias (56). The apparent over-representation 
in our identified studies of unusual pain syndromes (as 
discussed above) may reflect a similar process.
The majority of identified studies also focused on one 
specific pain subtype, thus perhaps limiting clinical 
generalisability, taking into account the frequent and 
reproducible observation in previous studies of MS-
related pain that patients often report multiple sites and 
types of pain, with temporal and anatomical overlap 
(6). Pain present at multiple sites cannot automatically 
be presumed to correlate to the same radiological 
abnormalities as those identified in limited studies of 
well-localised pain at a single site.
In 20.6% of the original articles, the main focus of 
the study was invasive pain treatment, and none 
investigated medical treatment of pain in MS (although 
pain medications were often described). This may 
in part reflect the increasing use of neurosurgical 
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treatments in MS (57), and several biases related to 
invasive therapeutic procedures in general (58). Trials 
of medical intervention in MS (for instance disease-
modifying therapy) commonly, however, report 
radiological outcomes.
The headache studies largely attempted to find 
neuroradiological correlates of specific headache 
subtypes. Studies of migraine (24), as well as unclassified 
headache (28), identified abnormalities in relation to 
the brainstem, a finding in keeping with the putative 
role of the brainstem in pain transmission pathways. 
Kister and colleagues, comparing MS groups with 
and without migraine, used a different approach. 
Instead of searching for a unique lesion responsible 
for the pain syndrome, they evaluated the localisation 
and total number of MS lesions of each patient. They 
found no differences in the number or distribution of 
lesions in the brain between the two groups, including 
the brainstem (30).
Studies characterising TN and trigeminal 
autonomic cephalalgias (TACs) however, focused 
(understandably) on abnormalities related to the 
trigeminal nucleus and nerve. Interestingly there 
appears to be some radiological overlap between 
findings in these groups of headaches, which are 
traditionally viewed as distinct in aetiology. The extent 
to which these findings are applicable to headache 
patients in general, remains unclear. The literature 
remains controversial regarding the origin of TN; 
MRI findings supported either the conclusion that MS 
lesions in the trigeminal pathways account for TN (13,
15, 19, 25), or the conclusion of a simultaneous role of 
central and peripheral trigeminal damage (20, 23).
The role of cervical spinal imaging in investigating 
headache aetiology (particularly, though not 
exclusively, when occipital, and thus hypothetically 
related to a cervical dermatomal distribution of pain) 
should also be borne in mind, as illustrated by the two 
cases identified here (11, 22). Despite the preponderance 
of headache and facial pain articles described in 
our review, possible conclusions are limited, and 
in particular our search strategy was not planned to 
investigate in detail specifics of management in TN, 
or neurophysiology of TACs.
The description of painful pupil-involving third nerve 
palsy as a symptom of brainstem demyelination (14) is 
of clinical interest, though such a possibility would 
only be considered following negative outcomes of 
emergent clinical investigation to exclude posterior 
communicating artery aneurysmal disease.
Lastly, considering limb and radicular pain, the 
limited data available suggest, as might be suspected 
on neuroanatomical grounds, that a spinal location 
of MS plaque should be considered. In particular, 
Hellwig, Tosi, and Burkey and colleagues (16, 29, 42),
identified dorsal cord lesions in the thoracic and/or 
cervical cord as associated with limb pain. These 
studies may potentially suggest a role of spinal 
lesions in either directly disturbing sensory afferent 
pathways, or perhaps in contributing to imbalance 
between spinothalamic and other sensory pathways, 
or dysfunction of descending inhibitory pathways (39).
The fact that pain research in MS with neuroimaging 
was predominantly on headache disorders biased also 
lesion localisation responsible for the different pain 
syndromes – it was more often the brainstem, followed 
by the spinal cord. To be noted is the absence of 
reports on pain caused by thalamic or cortical lesions, 
known to be responsible for pain syndromes, such 
as, post-stroke (59). Among the original articles only 
Svendsen and colleagues (39) compared and found no 
difference in the presence of lesions in the thalamus, 
capsula interna and thalamo-cortical projections in 
MS patients with or without pain. A non-significantly 
lower number of pain patients had lesions in thalamo-
cortical pathways. This apparent lack of interest in 
studying cortico-thalamic involvement in MS-related 
pain may be secondary to the emphasis given on white 
matter pathology in MS, although in the past years 
histopathological and MRI studies have shown that 
lesions are often located in the grey matter, especially 
in the cerebral cortex (1).
Methods used for identification of culprit MS lesions 
frequently relied on identifying plausibility using 
anatomical assumptions or a priori hypotheses 
regarding location. This approach, while based on 
established existing neuroanatomical knowledge, 
necessarily diminishes the likelihood of identifying 
novel anatomical sites of disease contributing to a 
particular pain syndrome. In only in a few cases was 
the suggestion of temporal association (and hence 
possible causality) between the lesion and the pain 
syndrome in question further strengthened by serial 
imaging and/or the use of intravenous contrast medium 
(see Table 5). Furthermore, the possible role of MS 
normal-appearing brain damage was never accounted 
for. The observations noted thus identified potential 
associations, rather than established causation.
The neuroimaging method used in all but one of the 
articles retrieved was MRI. As pointed out above, MRI 
was mostly used for lesion localisation, or to exclude 
other causes of neuropathic pain. We identified 
no functional or molecular imaging studies of the 
CNS, despite the great potential of these methods 
in unravelling, noninvasively, pain mechanisms in 
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health and disease (60). The single non-MRI study 
described in our review is a twenty-year-old paper 
from Ramirez-Lassepas and colleagues, where MS 
patients were also studied with computed tomography 
or myelography, techniques that do not have a routine 
role today in the diagnosis or follow-up of MS (38).
The description of image acquisition and reading 
protocols in the original articles was generally either 
insufficient or non-existent. The complexity of 
imaging techniques such as MRI, which include a 
diverse range of scanners and magnetic strengths, 
varied sequences and related procedures, inevitably 
causes marked variability, thus rigorous methodology 
and its reporting is necessary to ensure clarity, and 
reproducibility of results. This is particularly so when 
studying pain in MS, both demanding conditions 
imaging-wise: the first because it is elusive, and the 
second on account of the multiplicity of visible and 
invisible lesions and non-lesional pathology. In only one 
paper (19) were neuroimaging methods complemented 
by electrophysiological techniques, bringing time to 
space-resolution in the study of pain.
In addition, of these studies investigating 
neuroradiological abnormalities with pain, the 
blinding procedure (or lack of) was rarely reported. 
It was not always clear who read and interpreted the 
images (see Table 1). With regard to clinical case 
reports/series, blinding to patient’s clinical status was 
rare at time of reporting. We did not however identify 
any case studies in which further involvement of a 
blinded radiologist was mentioned. In the context of 
the research studies, this potential source of reporting 
bias should also clearly be considered.
Our study, to our knowledge, is the first to systematically 
review the literature on studies characterising pain 
in MS by neuroimaging assessment. A rigorous 
search strategy, supplemented by additional methods 
described above, was designed to optimise sensitivity 
of our study. The data supplied provide a summary 
of current understanding of MRI investigation of 
MS-related pain, while also usefully demonstrating 
potential for improvement in methodology.
Despite designing our strategy to optimise sensitivity, 
it is possible that relevant studies eligible for inclusion 
in our review were not identified by our search. Firstly, 
we restricted analysis of publications to studies 
published in the English language. It is also possible 
that studies reporting radiological assessment, as 
one aspect of a more general clinical evaluation 
or intervention, may not have been identified. In 
keeping with the strategy of sensitivity we have 
included studies, as discussed above, which do not 
fully describe diagnostic criteria used in application 
of the diagnosis of MS. Although all studies reported 
the inclusion of MS patients, the possibility of 
alternative or dual pathology contributing to pain 
needs to be borne in mind. While a dissemination bias 
favouring studies examining radiological correlates 
of headache and facial pain is suggested by our data, it 
is not possible to ascertain whether this may represent 
reporting, indexing, publication or inclusion bias, or a 
combination thereof (56).
Conclusion
Given the low number and quality of the articles 
collected in this review, and the underrepresentation 
of some relevant MS pain syndromes, we believe 
additional studies are needed. More evidence on pain 
mechanisms in MS is warranted, considering the high 
prevalence and impact of pain in this disease, and how 
little is known about its pathophysiology.
Neuroimaging methods, in particular functional and 
advanced structural MRI techniques, are ideal to study 
pain noninvasively in these patients, given already 
substantial contributions to both the MS and the pain 
fields. It is time to leave behind retrospective case 
reporting and produce novel experimentally designed 
studies to move forward in this area of investigation.
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Discussion forum
Accuracy, reliability, validity and limitations of functional
and structural magnetic resonance imaging data
Daniela Seixas a,b,c,* and Deolinda Lima a,b
a Institute of Histology and Embryology, Faculty of Medicine, Porto University, Porto, Portugal
b Instituto de Biologia Molecular e Celular, Porto, Portugal
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Brain imaging applications are numerous, and no longer
restricted to medicine or neuroscience: neuroimaging is
already in use for example in marketing, economics and
forensic science. While these other disciplines start to exploit
brain imaging, concerns are raised, and even if somewhat
behind the field, literature discussing imaging methodology,
neuroethics or philosophy of science is also emerging (Seixas
and Ayres Basto, 2008). Besides its complex nature, expensive
hardware and difficult interpretation, neuroimaging is more
and more available, and its potential uses are only limited
by imagination. And although neuroimages represent brain
data, they are also just pictures e that are worth a thousand
words (Roskies, 2007).
Structural neuroimaging, in general, deals with the struc-
ture of the central nervous system and is important for the
diagnosis of focal lesions of the brain in the individual patient,
as well as, for example, for the purpose of image registration.
Functional neuroimaging, on the other hand, studies brain
function, and the term characteristically applies to functional
magnetic resonance imaging (fMRI). fMRI detects changes in
blood oxygenation and flow that occur in response to neural
activity, but there are other imaging techniques that can
measure brain function, for example perfusion or
neurotransmission.
1. Structural imaging
In constant progress, structural magnetic resonance imaging
(MRI) is an established means to study brain structure,
acknowledged in 2003 when Paul Lauterbur and Sir Peter
Mansfield were awarded the Nobel Prize of Medicine and
Physiology for their discoveries regarding MRI. There are
several structural imaging techniques, and it is out of the
scope of this article to describe them in detail, but in general
they are highly reproducible and accurate. Sensitivity and
specificity with respect to pathology is amajor concern. Image
quality is particularly dependent on image resolution,
contrast, signal-to-noise ratio (SNR) and lack of image arti-
facts, and these parameters are affected, among others, by the
magnetic field strength and homogeneity.
In order to communicate neuroimaging results with
reference to brain anatomy, often it is necessary to register
different brain scans to each other, or to register a set of brain
scans to a template. Hence it is of extreme importance that
positions and dimensions correspond correctly across brain
images to accurately convey and compare data. Registration
algorithms are numerous and can generally be divided in
linear and non-linear. Although more time-consuming, non-
linear transforms are more accurate and seem to be little
affected by the choice of subject population, labelling
protocol, or type of overlap measure (Klein et al., 2009).
Other less palpable concerns about structural imaging,
with ethical and philosophical consequences, are incidental
findings. Incidental findings can be defined as suspicious
abnormalities that are unrelated to the purpose of the scan. A
recent meta-analysis assessed studies of asymptomatic indi-
viduals who underwent MRI of the brain for research, clinical,
occupational, or commercial purposes (Morris et al., 2009). In
16 studies, .7% of the people had tumoural incidental brain
findings, and 2.0% had non-tumoural incidental findings.
The number of asymptomatic people needed to scan to
* Corresponding author. Instituto de Histologia e Embriologia, Faculdade de Medicina da Universidade do Porto, Alameda Prof. Hernaˆni
Monteiro, 4200-319 Porto, Portugal.
E-mail address: dseixas@med.up.pt (D. Seixas).
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detect any incidental brain finding was 37, and the prevalence
of incidental findings was higher in studies using high
resolution MRI sequences than in those using standard
resolution sequences. The authors concluded that incidental
findings on brain MRI are common and that deserve to be
mentioned when obtaining informed consent, but are not
sufficient to justify screening healthy people. Other authors
argue that is neither feasible nor ethically required that
every research scan be examined by a qualified specialist
(Kirschen et al., 2006). Also, the increased detection of
lesions because of better conspicuity in higher resolution
scans should alert us for the problem of the meaning of
pathology that otherwise would not be detected.
Related to the issue of incidental findings is definitely the
problem of the meaning of abnormal structural imaging data.
If imaging abnormalities are readily identifiable, like a brain
tumour or a stroke, interpretation is usually straightforward.
However, not always brain MRI correlates well with clinical
findings, and uncertainty about their meaning is higher for
example in diseases like Alzheimer’s, epilepsy or multiple
sclerosis, where imaging anomalies are either late, structur-
ally difficult to demonstrate or diffuse.
The issue of interpretation of structural images is also
pertinent in foetal MRI, which contribution so far for the
understanding of the brain has probably been overestimated,
because the significance of findings in a developing central
nervous system is more ambiguous (Guibaud, 2009) and its
function cannot be easily accessed or predicted. Besides,
foetal imaging is associated with delicate ethical, moral and
social issues that are related with the possibility (depending
on the legal framework of each country) of pregnancy
interruption. A multidisciplinary approach to foetal
diagnosis should be the rule.
2. Functional imaging
The accuracy, reliability, validity and limitations of neuro-
imaging are more acute with functional imaging (and in
particular with fMRI), even though they also depend on
parameters that influence structural imaging as well, like the
field strength or the SNR. The problem begins with the
assumption behind the technique; fMRI by studying blood
oxygenation and flow is an indirect measure of brain activity.
Despite the fact that the phenomenon of neurovascular
coupling is well studied, it is still in debate (Attwell and
Iadecola, 2002). fMRI signal is relative (units are arbitrary)
and does not have a clear physiological meaning; in contrast
to computed tomography, for example, that measures
density of brain structures. Therefore comparisons across
MRI scanners or fMRI sessions are problematic. In addition,
design and theory of research, reliability and validity of
tasks, head motion (particularly task-correlated motion),
hardware and software diversity, and lack of normative
procedures all have an impact in fMRI results (Seixas and
Ayres Basto, 2008).
Another difficulty is that functional datasets are much
larger than structural datasets. A single subject’s brain may
contain 100,000 voxels (volume image elements) per image,
with several hundred of images per scan. And these obser-
vations are not independent of one another. There is then
a problem of multiple comparisons, but at the same time
corrections like Bonferroni’s, given the elevated number of
voxels, become too conservative for imaging data, and control
methods for family wise error like non-parametric permuta-
tion testing (Nichols and Holmes, 2002) or Gaussian random
field theory (Worsley et al., 1992) are preferred.
There are other important statistical problems with
current practices, namely power calculation, sample size,
false positives and false negatives, and region-of-interest
(ROI) analysis. Power calculation is complex in fMRI studies
because of the difficulty in estimating the variance of the
effect wanted to be detected; it depends, in a typical two-level
fMRI study, of the within-subject variance (on its turn
dependent on the design of the study) and of the between-
subject variance, and requires knowledge of the expected
percent signal change as well as estimates of the variability in
percent signal change (Mumford and Nichols, 2008).
Sample size on a first glance is a difficulty in fMRI studies
because these are expensive and time-consuming. Yarkoni
argues that in most fMRI experiments there is a pernicious
combination of small sample sizes, and stringent alpha-
correction levels because for group studies the main concern
is with controlling the rate of false positives (not to publish
false claims) (Yarkoni, 2009). This means that sensitivity is
often low with less than 50% chance of detecting an actual
activation. Increasing sample size (Fig. 1), or the scanning
time or the number of sessions will increase sensitivity
(particularly in single subject studies). Statistical methods
developed for fMRI were designed to detect an activation
rather than characterise it, and for example in single subject
studies for presurgical planning the extension of the maps is
of more importance; in research detection is often sufficient.
Also, in single subject studies type 2 error becomes more
Fig. 1 e The problem of statistical power in fMRI. There is an increase of number, extension and intensity of brain activation
clusters with increasing sample size, reflecting a higher sensitivity in detecting activations.
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relevant to ensure that the absence of an activation is not
claimed when in fact there was one, and so lower statistical
thresholds may be desirable.
The effects of non-independence on ROI analysis of fMRI
data have recently been raised in an article by Vul et al, noting
that a number of studies in the social neuroscience literature
reported ‘implausibly’ high correlations between brain
activity and behaviour (Vul et al., 2009). The authors argued
that non-independence, i.e., analyses where the choice of
voxels in the ROI analysis was made using the results from
the whole-brain analysis, was a source of bias. However
other authors believe that this bias is smaller than claimed
and recommend strategies to help limit the potential
problems caused by non-independence, like the strict
control for multiple comparisons and choosing the ROIs
before any data analysis has been performed (Poldrack and
Mumford, 2009).
Given this level of complexity, it is not surprising that
conventional statistical methods, like the general linear
modelling (GLM, multiple regression), are not necessarily the
best to explore brain function, even though they are imple-
mented inmany of thewidely used image processing software
(Monti, 2011). The GLM is quite flexible, allowing for various
testing strategies [for example the t test, the analysis of
variance (ANOVA) or analysis of covariance (ANCOVA)], but
introduces bias into estimates of variance, affecting test
statistics, power and false positive rates (Monti, 2011). There
are alternatives to the GLM, like independent component
analysis (Cole et al., 2010) or methods that while making use
of the GLM for the purposes of estimation, do not rely on it
for inference-making, namely non-parametric approaches
(Nichols and Holmes, 2002) or Bayesian methods (Friston
and Penny, 2003).
However, the ultimate fMRI issue is again the interpreta-
tion of results that many times is speculative, and not only
outside the neuroscience field. In the words of Nikos
Logothetis (2008) “The limitations of fMRI are not related to
physics or poor engineering, and are unlikely to be resolved
by increasing the sophistication and power of the scanners;
they are instead due to the circuitry and functional
organization of the brain, as well as to inappropriate
experimental protocols that ignore this organization.”
According to Hardcastle, there is a bias in neuroscience
toward localising and modularising brain functions
(Hardcastle and Stewart, 2002). At the same time, and
beautifully illustrated by Logothetis words, there is
a growing movement in the literature reinforcing integrated
views of the brain functioning.
Some fMRI applications raise particular ethical and moral
concerns that are not only related (among others) with the
nature of the study question but also with the limitations of
the technique. A few examples can be illustrative. fMRI has
been recently used to communicate with patients with
disorders of conscience, which are already a matter of debate
in disciplines like Philosophy, Psychology, Neurology and
Cognitive Neuroscience. Monti and co-workers designed two
fMRI tasks that allowed a small number of patients with
vegetative or minimally conscious states to wilfully modulate
their brain activity (Monti et al., 2010). The authors were
cautious in their interpretation of the results, reporting that
these only reflected some degree of awareness and
cognition. In other recent applications of fMRI, explanation
of results has not been so cautionary. Is fMRI ready to
predict deception for forensic purposes or personality traits?
Should fMRI be used in finding the commercial products that
stir our emotions or in choosing the winning political
candidate? It should be further noted that, so far, a normal
reference of brain function, as studied with fMRI, does not
exist, hindering the reliability of such applications at present
times. There should be a common effort to collect normative
functional data and to standardise tasks and procedures in
functional neuroimaging. Moreover, open-minded and
multidisciplinary approaches to fMRI and its ‘new’
applications are needed, because they are already in
development and in some cases in practical use. On the
other hand methodological, ethical and philosophical
constraints ought not to be an excuse to restrain fMRI,
a technique that has already contributed enormously, in the
past twenty years, in our understanding of the functions of
the human brain.
3. Final notes
Many of the key concerns on structural and functional
imaging were discussed briefly in this article. The focus was
mostly on the construction and contents of MRI representa-
tions of the brain, but the veiled power of images, as pointed
out in the introduction, is always latent and should be kept in
mind, since it can be used (consciously or not), in beneficial
and detrimental ways. Brain images are particularly valuable
in making complex data clearer or in helping a surgeon
explain the patient a certain procedure. It is an abuse however
to use them in court to convince a jury or tomake research data
more attractive.
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Summary:
Pain is a common symptom in multiple sclerosis. 
A single plaque can be its cause, and adds to the 
burden of disease, working in an already non-
resilient brain, imprinting uniqueness to multiple 
sclerosis central pain. Our objective was to study 
lesion topography and global brain integrity 
in chronic central pain of multiple sclerosis, 
comparing two groups, with (n=12) and without 
(n=11) pain. In addition to clinical, quantitative-
sensory, and neuropsychological measures, a 
multimodal neuroimaging protocol was designed to 
circumvent clinical-radiological discrepancies that 
included double inversion-recovery, and measures 
of myelin structure, water diffusion, brain volume 
and perfusion. Mean duration of pain was 7.6 
years; pain patients had worse general health 
and quality-of-life, and were more depressed and 
hypervigilant; temperature abnormalities were 
the most frequent. Lesion location that most often 
explained pain was the spinal cord (n=8). Among 
patients with and without pain, thalamic lesions 
were common, with a tropism for the medial 
thalamus. Comparing patients with bilateral pain 
with the no-pain group there were significant 
increases in connectivity scores for the thalamus 
with the cingulate and insular cortices. The volume 
of normal-appearing white matter was reduced in 
the pain relapsing-remitting subgroup, and these 
had increased myelin water fraction in the splenium 
and internal capsule, and reduced residence time 
in the corona radiata. Myelin water fraction was 
positively correlated with pain, and residence time 
negatively correlated with pain duration in the 
corpus callosum. Patients with pain showed also 
increased perfusion in the somatosensory cortex. 
Our psychophysical results are in concordance with 
previous research, suggesting that the phenotype 
of central pain in multiple sclerosis is identical to 
other central pains. However, our data also suggests 
that even though thalamic lesions may be common 
in multiple sclerosis, the plaques that more likely 
cause pain are in the spinal cord. We have found 
several measures of brain structural and functional 
dysfunction: the increased connectivity between 
brain regions involved in pain processing, and 
in pain patients a decreased volume of normal-
appearing white matter, myelin disorganisation, 
and increased perfusion in the primary somatic 
area. These brain changes may not be contributions 
of pain, but instead consequences of chronic pain 
originating in the spinal cord in multiple sclerosis.
Keywords: pain, multiple sclerosis, magnetic resonance imaging, thalamus, spinal cord
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1. Introduction
Multiple sclerosis (MS) is an inflammatory disease of 
the central nervous system (CNS) and is associated 
with demyelination and secondary neurodegeneration 
(Hohlfeld and Wekerle, 2004). More than a decade ago, 
pain was acknowledged as being a common symptom 
in MS (Clifford and Trotter, 1984). Pain syndromes 
in MS are varied and may coexist, from nociceptive 
to neuropathic, and include extremity pain, trigeminal 
neuralgia, Lhermitte’s sign, painful tonic spasms, 
back pain, and headache. In the case of central pain, a 
single CNS lesion can be its cause and this adds to the 
burden of the disease. In addition, it is recognised that 
other demyelinating plaques and hidden pathology 
on conventional magnetic resonance imaging (MRI) 
– the cortex and normal appearing white matter 
(NAWM) – might contribute to MS pain, but this is not 
understood. The CNS in MS is already non-resilient, 
and this imprints uniqueness in MS pain compared 
to other pain syndromes; how this contributes to the 
development and maintenance of chronic pain states 
in this disease is unclear. To date, few studies have 
examined the underlying mechanisms of pain in MS 
or in experimental autoimmune encephalomyelitis 
(EAE: an animal model of MS).
In humans, Cruccu and colleagues investigated the 
mechanisms of trigeminal neuralgia in MS using 
trigeminal reflex testing and MRI, finding that the most 
likely cause of MS-related trigeminal neuralgia are 
plaques damaging the primary afferents (Cruccu et al., 
2009). Study results from Österberg and Boivie using 
quantitative sensory testing (QST) and comparing a 
group of patients with MS and central pain with a group 
of patients with MS and sensory symptoms support 
the hypothesis that only patients who have lesions 
affecting the spinothalamo-cortical pathways run the 
risk of developing central pain (Österberg and Boivie, 
2010). A recent review by O’Connor and colleagues 
proposes a new classification of pain associated with 
MS (O’Connor et al., 2008). However, this work was 
largely phenomenological, as direct studies on pain 
pathophysiology in MS patients are difficult to carry 
out and thus remain rare; pain in MS was compared 
to post-stroke pain (O’Connor et al., 2008), a relation 
not formally investigated to date.
Characterising MS using imaging has proven to be 
a challenge, showing relatively modest relationships 
between conventional MRI measures and clinical 
status. Nonetheless, MRI is able to provide an in vivo 
examination of the human brain that is invaluable 
for the disease diagnosis (Polman et al., 2011), and 
MRI is thought to be between five and 10 times more 
sensitive to ongoing focal demyelination than clinical 
measures (Simon et al., 2006).
Novel MRI techniques that go beyond conventional 
anatomical imaging have demonstrated the ability to 
image underlying pathological processes in MS other 
than pain, and multimodal imaging is believed to be 
particularly powerful for this application (Bakshi et 
al., 2008). Diffusion-based measures like diffusion 
tensor imaging (DTI) and myelin-selective imaging 
techniques like multi-component T2 mapping are more 
sensitive; specific MRI techniques that can be used 
to study NAWM may offer insight regarding myelin 
and axonal integrity (Laule et al., 2007). Diffusion 
MRI has been shown to be exquisitely sensitive to 
alterations in white matter microstructure (Basser and 
Pierpaoli, 1996), but suffers from a lack of specificity 
as it is governed by properties like axonal diameter, 
packing, and other properties (Beaulieu, 2002).
Multicomponent T2 relaxation imaging can be 
used to measure signal from water trapped between 
the myelin bilayers from intra- and extra-cellular 
water. The myelin-associated water volume fraction, 
called the myelin water fraction (MWF), has been 
shown to correlate strongly with histopathological 
measurements of myelin content (Laule et al., 2007), 
and reductions in MWF in NWAM have been shown 
to correlate with disability in MS (Kitzler et al., 2012; 
Kolind et al., 2012).
From a functional rather a structural perspective, 
arterial spin labeling (ASL) is a noninvasive 
method to measure brain perfusion with MRI and 
is an alternative to perfusion-weighted imaging 
that involves an external contrast agent. Water from 
circulating arterial blood is magnetically labeled 
and acts as a diffusible tracer allowing non-invasive 
measurement of cerebral blood flow (CBF). ASL 
perfusion has a broad range of potential applications 
as a biomarker of regional brain function (Detre et al., 
2009), and there is growing interest in its application 
to study ongoing pain states.
Our objective was to study central neuropathic pain 
in MS, unravelling some of the pathophysiological 
pain mechanisms and consequences in this disease, in 
particular lesion topography and global brain integrity 
using measures of myelin structure, water diffusion, 
brain volumes and perfusion. For this purpose, 
and in addition to clinical, quantitative-sensory, 
and neuropsychological measures, a multimodal 
MRI protocol was designed to circumvent clinical-
radiological discrepancies in MS, by imaging in 
detail white (including NAWM) and grey matter, 
the supra and the infratentorial brain, and the spinal 
cord – often neglected in MS imaging studies yet of 
major pathophysiologic importance for pain related 
symptoms.
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Central pain in MS: a neuroimaging study 3
2. Methods
A case-control study was designed that included 
23 MS patients attending the MS clinic at the John 
Radcliffe Hospital in Oxford, United Kingdom. The 
patients were between 18 and 55 years of age, had a 
definitive diagnosis of MS (according to the revised 
McDonald criteria (Polman et al., 2005)), and no 
contraindications for MRI. The case (pain) group 
consisted of 12 consecutively recruited patients with 
chronic (more than three month duration) central 
neuropathic pain. A control group of 11 MS patients 
without pain matched the case patients with respect to 
age, gender, subtype and duration of MS and Expanded 
Disability Status Scale (EDSS) score (the most 
commonly used quantitative system for measuring 
disability in MS (Kurtzke, 1983)). Patients with 
serious cognitive impairment, depression or fatigue, 
or with other neurological diseases, cancer, diabetes 
or renal disease were excluded. Forty-four patients 
were contacted; 21 patients declined to participate or 
did not meet the inclusion criteria. The Oxfordshire 
Research Ethics Committee approved the study.
The research protocol consisted of neurological, 
psychological and quality-of-life measures, QST, and 
MRI.
2.1 Neurological, psychological and quality of life 
measures
Behavioural testing began with the completion of a 
number of self-administered questionnaires: Hospital 
Anxiety and Depression Scale (HADS) (Zigmond 
and Snaith, 1983), The Medical Outcome Study Short 
Form 36 (SF36) (Aaronson et al., 1998), Modified 
Fatigue Impact Scale (MFIS) (Fisk et al., 1994), MS 
Neuropsychological Screening Questionnaire (MSNQ) 
(Benedict et al., 2003), and The Pain Vigilance and 
Awareness Questionnaire (PVAQ, in chronic pain 
patients, preoccupation with or attention to pain is 
associated with pain-related fear and perceived pain 
severity) (Roelofs et al., 2003). Individuals with pain 
completed the short version of the questionnaires: 
The Brief Pain Inventory (BPI) (Osborne et al., 2006) 
and The McGill Pain Questionnaire (MPQ) (Melzack, 
1987). For a detailed description of the applied 
measures, please refer to the references.
2.2 Quantitative sensory testing
All subjects with pain underwent QST according 
to the protocol developed by the German Research 
Network on Neuropathic Pain (Rolke et al., 2006). 
The QST assessment, comparing the pain area with 
the contralateral non-affected side, included: cold and 
warm detection thresholds, the thermal sensory limen 
procedure, cold and heat pain thresholds, mechanical 
detection threshold, mechanical pain threshold, and 
vibration disappearance threshold. QST data were 
assessed for normality of distribution and logarithmic 
transforms were applied to non-normally distributed 
data, which is in line with previous descriptions.
2.3 Magnetic resonance imaging
Structural imaging
Imaging was conducted using a 3 tesla MRI scanner 
(Siemens TIM Trio) and a 12-channel head coil, in 
a single session. Structural MRI sequences covering 
the whole brain included T1-weighted magnetisation 
prepared rapid acquisition gradient echo (MPRAGE) 
(Mugler and Brookeman, 1990), fast spin echo (FSE) 
for PD- and T2-weighted images, T2 fluid-attenuated 
inversion recovery (FLAIR) (Hajnal et al., 1992) and 
double inversion recovery (DIR) for images with 
both cerebrospinal fluid (CSF) and white matter 
suppression (Boulby et al., 2004; Redpath and Smith, 
1994). For spinal cord imaging T2 FSE images were 
acquired in the sagittal plane. The imaging parameters 
were as follows: T1 MPRAGE (TR/TE = 2040/4.7 
ms, 192 × 192 matrix, one signal average, 192 mm 
field of view, slice thickness 1 mm, 192 slices), T2/
PD FSE (TR/TE1/TE2 = 4620/26/105 ms, 256 × 256 
matrix, one signal average, 256 mm field of view, 
47 contiguous 3 mm slices), T2 FLAIR (TR/TE/TI 
= 9000/90/2500 ms, 256 × 256 matrix, one signal 
average, 220 mm field of view, 47 contiguous 3 mm 
slices), DIR (TR1/TR2/TE = 2930/9000/353 ms, 256 
× 256 matrix, one signal average, 310 mm field of 
view, slice thickness 3 mm, 88 slices), T2 TSE sagittal 
spine (TR/TE = 3480/135 ms, 448 × 448 matrix, three 
signal averages, 250 mm field of view, 10 slices of 2.5 
mm with a distance factor of 10%).
A trained neuroradiologist (D.S.) blinded to the 
patient status evaluated all structural MRI sequences 
of each patient, identifying MS plaques located 
throughout the somatosensory pathways (spinal cord, 
medulla oblongata, pons, mesencephalon, internal 
capsule, thalamus, and thalamo-cortical projections 
to primary sensory cortex). After lesion identification, 
their location was compared to the pain distribution 
in the body to determine the lesion most likely to be 
responsible for the pain syndrome of each individual 
patient. Patients with multiple lesions that could 
potentially explain their pain were excluded from 
further assessment. Thalamic lesions were especially 
characterised in both groups (pain and no pain).
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Brain volumes
Brain tissue volume was estimated with SIENAX 
(Smith, 2002a; Smith et al., 2001), part of FSL 
(FMRIB’s Software Library; www.fmrib.ox.ac.uk/
fsl) (Smith et al., 2004), and normalised by head size. 
SIENAX starts by extracting brain and skull images 
from the single whole-head input data (Smith et al., 
2002b). The brain image is then affine-registered to 
Montreal Neurological Institute (MNI 152) space 
(Jenkinson and Smith, 2001; Jenkinson et al., 2002) 
(using the skull image to determine the registration 
scaling); this is primarily used to obtain the volumetric 
scaling factor, to be used as a normalisation for head 
size. Next, tissue-type segmentation with partial 
volume estimation is carried out using FAST (Zhang 
et al., 2001) in order to calculate total volume of brain 
tissue (including separate estimates of volumes of 
grey matter, white matter, peripheral grey matter and 
ventricular CSF).
Diffusion imaging and tractography
Diffusion-weighted images were acquired using a 
twice-refocused spin echo sequence (Reese et al., 
2003) (b = 1000 s/mm2; TR = 9300 ms; TE = 94 
ms; 65 slices; 2mm isotropic resolution; two signal 
averages), along 60 directions.
Probabilistic diffusion tractography was carried out 
according to previously detailed methods (Behrens 
et al., 2003a,b). Using Bayesian techniques, we 
estimated a probability distribution function (PDF) 
on the principal fibre direction fitting up to two fiber 
orientations per voxel (Behrens et al., 2007). Probability 
distributions of connectivity between a seed region 
and all other points were generated by repeatedly 
sampling connected pathways through this PDF field 
using probabilistic tractography, to build a probability 
distribution on the location of the dominant connection 
from the seed voxel. We manually outlined the whole 
thalamus and eight cortical regions (prefrontal, posterior 
parietal, temporal, occipital, primary and secondary 
somatosensory, primary motor and premotor, insular 
and cingulate cortices) on each subject’s T1-weighted 
image using anatomical landmarks detailed previously 
(Behrens et al., 2003a). For tissue-type segmentation, 
skull stripping and registration, tools from FSL were 
used. From each voxel in the thalamus mask, we 
drew samples from the connectivity distribution and 
recorded the number of samples that passed through 
each cortical mask. For each thalamic voxel in standard 
space we calculated a probability of connection to each 
cortical zone as a proportion of the total number of 
samples from that voxel that reached any cortical area. 
Hand segmentation of the thalamus was performed by 
classifying seed voxels as connecting to the cortical 
mask with the highest connection probability, resulting 
in exclusive connectivity-defined regions. For each 
cortical area, we thresholded and binarised individual 
subject results to include only those thalamic voxels 
with a connection probability >25%. These images 
were overlaid to create group probability maps of 
thalamic sub-regions.
Myelin water imaging
Multi-component relaxation imaging can provide 
information regarding water in different physical 
compartments, specifically a fast-relaxing component 
associated with myelin water and a slow-relaxing 
component associated with intra/extracellular water 
(MacKay et al., 1994). In this study, we acquired 
and analysed data using the multi-component driven 
equilibrium single pulse observation of T1 and 
T2 (mcDESPOT) technique (Deoni et al., 2008). 
Acquisition consisted of a series of spoiled gradient 
recalled echo (SPGR) and balanced steady-state 
free precession (bSSFP) images over a range of flip 
angles. Additional scans with inversion recovery and 
phase cycling were acquired to allow correction of 
off-resonance effects and flip angle variations (Deoni, 
2011). Images were linearly co-registered (Jenkinson 
and Smith, 2001), and non-brain signal removed (Smith, 
2002a); a two-compartment SPGR and bSSFP model 
was fit to the data voxel-wise (Deoni et al., 2008), to 
obtain whole brain maps of the MWF and myelin water 
residence time. To spatially compare relaxometry 
metrics across subjects and between groups, we applied 
tract-based spatial statistics (TBSS) (Smith et al., 2006) 
to the MWF data as previously described (Kolind et al., 
2012). Briefly, TBSS reduces biases due to inaccurate 
spatial registration by performing analysis along a 
skeletonised white matter mask representing the mid-
line of each white matter pathway. The myelin water 
residence time maps were also projected onto the white 
matter skeleton using the transforms determined for the 
MWF data. Group differences in relaxometry metrics, 
and relationships between these metrics and clinical 
measures were tested using Randomise (Nichols and 
Holmes, 2002) along the TBSS skeleton. Statistical 
significance was defined as p < 0.05, corrected for 
multiple comparisons by controlling family-wise error 
rate after threshold-free cluster enhancement (TFCE) 
(Smith and Nichols, 2009).
Perfusion
A non-contrast-agent MRI technique, ASL (Detre 
et al., 1992), was used to measure brain perfusion. 
Flow-sensitive alternating inversion recovery ASL 
was used to produce perfusion-weighted image by 
subtracting tag images from control images. A 3D 
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gradient and spin echo (GRASE) readout was used 
for imaging (Günther et al., 2005). The GRASE-ASL 
imaging volume was 200 mm × 200 mm × 96 mm 
(half k-space coverage; 64 × 64 × 24 matrix size; 
voxel dimensions: 3.1 mm × 3.1 mm × 5.0 mm). The 
TR and TE were 3070 and 23.8 ms, respectively. 
Background suppression of static tissue was achieved 
using two nonselective inversion pulses, prescribed at 
times to null signal from grey matter and white matter. 
The top and bottom three slices in each ASL imaging 
volume were excluded due to wrap around in the z-
direction in some participants. Ten inflow times (TI) 
were used starting at 400 ms, incrementing by 200 ms, 
with the longest TI equal to 2200 ms. There were 80 
measurements for the eight minutes and 11 sec ASL 
scan, which produced 10 average difference images. 
A 6-mm full-width-half-maximum spatial smoothing 
kernel filter was applied to the ASL difference images. 
ASL voxels in the brain were extracted using a brain 
extraction tool, supplied as part of FSL (Smith, 
2002a). CBF and arterial arrival time (AAT) maps 
were produced by fitting an ASL model to the data 
(Chappell et al., 2010). Nonparametric permutation-
based group comparisons were performed on a voxel-
by-voxel basis for CBF and AAT maps. For CBF 
data, images were normalised on a per patient basis 
by using the ratio of grey matter to white matter mean 
values. In addition, whole brain and thalamus region 
of interest analyses were performed to compare groups 
(pain and no pain).
For CBF quantification, a calibration scan was 
acquired to calculate the initial magnetisation of 
arterial blood water. Identical imaging dimensions 
with the following imaging parameters changed: TR 
(6000 ms), TI (5000 ms), no background suppression. 
CSF voxels were isolated by manual segmentation 
and used to convert CBF images to absolute units 
using a known proton density ratio between CSF and 
blood (Wu and Wong, 2006). Registration to anatomic 
and standard space images was performed using a 
linear image registration tool in a two-step process 
(Jenkinson et al., 2002).
2.4 Statistical analyses
Distributions by frequency were generated for every 
categorical variable for the descriptive aspects of the 
analysis. For homogenous variances, the Student’s t 
test was used to compare the patient groups or body 
regions. For non-homogenous variances, the Mann-
Whitney test was adopted. The chi-square test or the 
likelihood ratio was used for comparisons between 
categorical variables. Parametric statistics were 
applied where normality was seen in the original 
or transformed QST data. Relationships between 
age, disease duration, neurologic symptom severity 
(EDSS) and pain intensity were assessed using 
Spearman or Pearson correlation coefficients as 
appropriate. Statistical significance was accepted at 
p < 0.05. Statistical analyses were performed using 
SPSS (SPSS software INC) and results are presented 
as mean and standard error of the mean (SE).
3. Results
3.1 Patient details
The group of MS patients with chronic neuropathic 
pain consisted of 10 females and two males, and the 
control group (no pain) consisted of nine females and 
two males. Mean age was 48.4 years (SE 2.7) and 
46.9 years (SE 2.5), mean duration of the disease 
(from time of first symptoms) was 13.3 years (SE 
2.8) and 12.3 years (SE 2.1), and mean EDSS was 4.8 
(SE 0.6, median 5.3, min 1, max 8) and 4.7 (SE 0.6, 
median 4.5, min 1.5, max 8), for the pain and control 
groups, respectively. Regarding the distribution of 
patients according to MS subtype, in each group seven 
patients had relapsing-remitting (RR) MS and four 
patients secondary progressive MS; one patient in the 
pain group had primary progressive MS. There were 
no statistical differences between groups for gender 
(p=0.924), age (p=0.657), MS duration (p=0.951), 
and EDSS score by categories (0.0-4.5 and 5.0-9.5) 
(p=0.827). A summary of the patient demographics 
and clinical characteristics is provided on Table 1. 
There was also no total lesion volume difference 
between groups (p=0.101). 
3.2 Behavioural and psychophysical results
Mean duration of pain was 7.6 years (SE 2.5, median 
4.5); 83.3% of the patients had pain at the time of 
diagnosis. Mean pain intensity was 5.5 on an 11-point 
scale (SE 0.3, median 5.0). The word from the MPQ 
most frequently used to describe pain was the sensory 
descriptor, ‘sharp’, in 75% of the cases; the affective 
quality of pain most often reported was sickening 
(58.3%). All of the patients believed their respective 
pains were caused by MS. Considering pain treatment, 
91.7% of the patients required daily medication, and 
75% used multiple drugs; mean relief obtained was 
49.2% (SE 8.4). Ninety one percent of the patients 
used non-drug treatments for pain. The control group 
had better general health than the case group (SF36, 
p=0.003); pain interfered with walking, work and 
sleep (BPI). In comparison to controls, pain patients 
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Table 1 Demographic and clinical characteristics of the MS patient sample.*
  Pain group Control group
Mean age in yearsn.s. 48.4 (2.7) 46.9 (2.5)
Gendern.s.
Male n=2 n=2
Female n=10 n=9
Mean education in years 12.8 (1.1) 14.9 (0.9)
Race/ethnicity
Caucasian n=12 n=11
Marital status
Married or living as married n=6 n=9
Single n=2 n=2
Divorced n=4 n=0
Widowed n=0 n=0
Mean disease duration in yearsn.s. 13.3 (2.8) 12.3 (2.1)
Mean years since diagnosisn.s. 6.3 (1.6) 10.2 (1.9)
Mean EDSS scoren.s. 4.8 (0.6) 4.7 (0.6)
MS subtype
Relapsing-remitting n=7 n=7
Secondary progressive n=4 n=4
Primary progressive n=1 n=0
*Values are the mean and standard error unless otherwise indicated. n.s., not significant p>0.05. EDSS, expanded 
disability status scale
Table 2 Perception thresholds in MS patients with pain. P-values show the results 
of statistical tests of significant differences between the pain regions and the control 
body regions
  Pain area   Control area
  Mean Median SE Mean Median SE p-value
Sensory abnormalities       
Warmth (ºC) 41.4 38.8 1.7 37.6 35.9 1.2 0.010
Cold (ºC) 20.6 25.7 3.2 24.7 27.4 2.4 0.102
Difference limen (ºC) 18.7 10.9 4.2 14.1 7.6 4.0 0.116
Heat pain (ºC) 45.0 45.6 1.2 42.8 43.6 1.6 0.209
Cold pain (ºC) 7.8 1.2 3.1 13.9 13.0 3.3 0.046
Mechanical detection (mN) 11.7 11.0 2.5 4.6 3.4 0.9 0.014
Mechanical pain (mN) 241.9 128.0 59.8 181.3 100.0 47.1 0.352
Vibration disappearance (/8) 4.9 4.6 0.5 5.7 5.4 0.4 0.008
were more depressed (p=0.0046), and in the RR 
subgroup more hypervigilant to pain (p=0.0016). No 
difference was found pertaining to anxiety (p=0.2838), 
fatigue (p=0.197) or cognitive impairment (p=0.2838) 
between groups.
Regarding QST, all pain patients had abnormal 
sensibility for one or more of the modalities tested 
(comparing the pain area with the contralateral non-
affected side), but temperature abnormalities were 
the most frequent. Details of the results from the 
quantitative examinations comparing body regions 
with pain with body regions without pain (whenever 
possible the contralateral area) are presented in Table 2. 
Significant differences were found between the pain area 
and the control area concerning the warmth detection 
threshold (p=0.010), the cold pain threshold (p=0.046), 
the mechanical detection threshold (p=0.014) and the 
vibration disappearance threshold (p=0.008).
3.3 Anatomical, diffusion, volumetric and perfusion 
imaging results
Figure 1 illustrates location of pain in each patient. We 
were also able to identify lesions likely responsible 
for the pain in 10 out of the 12 pain patients. Eight 
patients had lesions in the spinal cord: four in the 
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Fig. 1 Pain drawings of the 12 MS patients with chronic neuro-
pathic pain. Patient number and MS lesion location most likely 
responsible for the pain are shown below each patient drawing. In 
two cases (patients 3 and 9) lesion topography responsible for the 
pain was impossible to determine
cervical segment (patients 1, 2, 4 and 6), one in the 
thoracic segment (patient 5) and three in the lumbo-
sacral segment (patients 7, 8 and 11). One patient had a 
lesion in the medulla oblongata (patient 10) and another 
in the ventral thalamus (patient 12). The specific 
lesions, as demonstrated by MRI, responsible for the 
pain syndromes of patients 10 and 12 for example, 
are represented in Figures 2 and 3, respectively. 
Accompanying the hemibody pain syndrome and the 
contralateral ventral thalamic plaque of patient 12, we 
have found, with the same topography as the pain, 
thermal (cold/warm) and tactile sensory loss, and 
thermal (cold/heat) hypoalgesia, using a contralateral 
non-affected skin area as control. It was not possible 
to isolate the pain syndrome to a unique lesion in 
two patients, because there were multiple lesions in 
the somatosensory pathways that could potentially 
explain the pain.
Within the total group of 23 patients, eleven patients 
had thalamic lesions (bilateral in six cases): seven 
patients in the pain group and four patients in the control 
group. In only one patient (patient 12) a thalamic 
lesion explained the pain (Figure 3). Considering the 
distribution of the patients’ lesions inside the thalami, 
the majority of MS plaques were medially situated 
(Figure 4). In patients both with and without pain, as 
determined by probabilistic tractography, the cortical 
regions that had higher connectivity scores with 
the thalamic lesions were the motor and premotor 
cortices (Table 3). However, comparing the subgroup 
of patients with bilateral pain (n=4) with the control 
group there were significant increases in connectivity 
scores for the left thalamus with the cingulate gyrus 
(p=0.04) and for the right thalamus with the insular 
cortex (p=0.04). There were no differences in thalamic 
volume (p=0.65) or perfusion (p=0.09) between the 
pain and no pain MS groups.
No statistical differences were found regarding 
total brain volume (p=0.715), white matter volume 
(p=0.668), or grey matter volume (p=0.395) between 
groups. Among RR MS patients (n=7 in the pain group 
and n=7 in the control group), the volume of NAWM 
was reduced for pain patients compared to the control 
patients (p=0.029). Patients in the pain group showed 
increased perfusion compared to the control patients 
in the right somatosensory cortex (coordinates: X=27 
mm, Y=-27 mm, Z=66 mm; uncorrected p<0.0001, 
corrected p<0.1); no other brain regions survived the 
correction for multiple comparisons.
Fig. 2  Axial T2 TSE cerebral MRI. This patient had left facial 
pain and a lesion in the ipsilateral medulla oblongata (arrow).
Fig. 3 Axial T2 DIR and T1 MPRAGE cerebral MRI. This patient 
had right hemibody pain and a lesion on the left thalamus (arrow). 
Fig. 4 Mean map across all patients (n=23) of thalamic lesions 
(registered in standard space; left thalamic lesions represented in 
green, and right thalamic lesions represented in blue), with a tro-
pism for the medial thalami.
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Table 3 Number of thalamic lesions for each cortical region with higher probability 
of thalamic connectivity
Number of thalamic lesions
Cortical regions Pain group Control group
Primary motor (M1) and premotor (PMC) cortices 5 4
Prefrontal cortex (PFC) 2 0
Temporal cortex 1 1
Primary (S1) and secondary (S2) somatosensory cortices 1 0
Posterior parietal cortex 1 1
Insula 0 1
Cingulate cortex 0 0
Occipital cortex 0 0
3.4 Myelin water imaging results
Voxel-wise comparisons of MWF and myelin water 
residence time between MS patients with and without 
pain along the TBSS skeleton did not reveal any 
significant differences. However, as shown in Figure 5, 
in the subgroup of patients with RR MS, patients with 
pain had increased MWF in the splenium and right 
retrolenticular part of the internal capsules (9% higher 
across the entire skeleton, p=0.08, and 31% higher in 
areas shown in orange in Figure 5, p=0.0001), and 
reduced myelin water residence times in the posterior 
corona radiata (4% lower across the entire skeleton, 
p=0.04, and 31% lower in areas shown in blue in 
Figure 5, p=0.0001), though the differences did not 
reach voxel-wise significance. 
No significant correlations were found between pain 
metrics and MWF or myelin water residence time 
when all MS patients were included, but trends were 
found within the RR MS group. As shown in Figure 6, 
in patients with pain, MWF was positively correlated 
with average pain, primarily in the corpus callosum 
(R=0.67, p=0.05 in the areas shown in red in Figure 6), 
and for whole brain analysis at p=0.05. Myelin water 
residence time was negatively correlated with pain 
duration in the genu of the corpus callosum (R=-0.89, 
p=0.003 in the areas shown in blue in Figure 6).
Fig. 5 While not reaching voxel-wise significance, myelin water fraction (MWF) was found to be higher in RR MS patients with 
chronic pain than those without, particularly in the splenium and right retrolenticular part of the internal capsules (p<0.07 shown spa-
tially on the top left) with average values from the region shown in orange in the graph on the top right. Myelin water residence time 
was shorter for the RR MS patients with chronic pain, particularly in the posterior corona radiata (p<0.07 shown spatially on the bottom 
left) with average values from the region shown in blue in the graph on the bottom right.
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Fig. 6 While not reaching voxel-wise significance, myelin water fraction (MWF) was found to be higher in RR MS patients with higher 
intensity pain, particularly in the corpus callosum (p<0.07 shown spatially on the top left) with the relationship within the region shown 
in red in the graph on the top right. Myelin water residence time was shorter for the RR MS patients longer pain duration, particularly 
in the posterior genu of the corpus callosum (p<0.07 shown spatially on the bottom left) with the relationship within the region shown 
in blue in the graph on the bottom right.
4. Discussion
The present study is focused on chronic central pain in 
MS patients comparing two matched groups of patients 
with MS, with and without pain. Our behavioural and 
psychophysical results are in accordance with data 
obtained from other chronic central pain syndromes 
(Boivie et al., 2011). Pain patients had worse general 
health and quality-of-life, and were more depressed and 
more hypervigilant than the case group. Concerning 
QST data and the comparisons made between painful 
and non-painful regions in the patient group, these 
revealed the threshold values to be significantly more 
abnormal in the pain regions for warmth and cold 
pain, results similar to those found by Österberg and 
colleagues (Österberg and Boivie, 2010).
4.1 Lesion topography
MRI studies show that spinal cord abnormalities in 
MS are highly prevalent, are found in 80–90% of 
patients, and are more often symptomatic than brain 
plaques (Honig and Sheremata, 1989; Kidd et al., 
1993; Tartaglino et al., 1995; Thorpe et al., 1996). The 
finding in our cohort that most of the pain syndromes 
were possibly caused by spinal cord lesions (eight 
out of 12), although not previously shown before, 
is hence not surprising. Grau-López and colleagues 
foresaw this result in a recent study demonstrating 
an association between the presence of lesions in the 
spinal cord and pain in MS patients (Grau-López et 
al., 2010). Finding that MS central pain may be caused 
primarily by spinal cord plaques is of great importance 
for future research, and for the treatment of pain in 
MS, in better targeting both drugs and interventions 
such as deep brain or cord stimulation.
The involvement of grey matter structures in MS is 
well known, even in the earliest stages of MS (Pirko 
et al., 2007). However, the high frequency of thalamic 
lesions in our patients did not explain most of the 
pain; in only one patient did we believe a thalamic 
lesion was the origin of the pain syndrome (patient 
12). Also, the thalamic region described as most often 
involved in central pain is the ventroposterior nuclei 
(Boivie, 2011), yet we have demonstrated that most 
of the lesions found were medially located in the 
thalamus (Figure 5).
4.2 Global brain structural and functional changes
Using tractography, the preferential connectivity 
probability for the left thalamus with the cingulate 
gyrus and for the right thalamus with the insular cortex 
that we have identified by comparing the subgroup of 
patients with bilateral pain with the control group (no 
pain), fits with our current knowledge of pain networks, 
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nonetheless needs further validation and a larger 
cohort. Although these are brain regions recognised as 
heavily involved in pain processing (Apkarian et al., 
2005; Tracey, 2011; Tracey and Mantyh, 2007), the 
meaning of this increased strengthening of possible 
connectivity between these areas is as yet, unclear.
We have found that the volume of NAWM was 
reduced in the subgroup of pain patients with RR MS 
compared with the group of RR patients without pain. 
Even though most of the reported findings in chronic 
pain refer to grey matter changes – both increases and 
decreases in volume measurements alongside recovery 
of such changes with successful pain relief have been 
described (Apkarian et al., 2004; Burgmer et al., 
2009; Gwilym et al., 2010; May, 2008; Schweinhardt 
et al., 2008) – there are studies highlighting changes 
in white matter in complex regional pain syndrome 
(Geha et al., 2008). What these changes signify 
regarding either adaptation to or maladaptive 
consequences of the pain are, as yet, unknown. The 
fact that MS is a demyelinating disease and changes 
in white matter have been identified in chronic pain 
conditions, suggests a link to pain chronicity in 
altering ‘vulnerable’ or non-resilient white matter. For 
RR MS patients, those with chronic pain were found 
to have lower MWF values and shorter myelin water 
residence time than patients without, and relationships 
were noted between pain intensity and MWF, and 
between pain duration and reduced myelin water 
residence time. While the increased MWF values may 
suggest increases in myelin, the reduced myelin water 
residence time hints that the myelin integrity may be 
reduced; these results argue for a probable myelin 
disorganisation associated with the pathophysiology 
of pain in MS. Further validation work is needed, 
but these results support the hypothesis that myelin 
integrity in NAWM is implicated in chronic pain. 
Whether this is the brain adapting to the altered body 
schema and biomechanics consequent to pain or is 
directly caused by the incessant nociceptive barrage 
is something that needs to be explored in longitudinal 
studies.
Brain functional activation caused by painful stimuli 
has already been studied with ASL (Howard et al., 2011; 
Owen et al., 2012), and blood flow regional increases 
as measured indirectly with functional MRI (fMRI) 
and positron emission tomography (PET) or single-
photon emission computed tomography (SPECT) are 
frequently observed in the primary somatic area, in 
the secondary somatosensory, insular and anterior 
cingulate cortices, and in the thalamus (Peyron et al., 
2000). In chronic pain, however, the literature is not 
so coherent; there are results from SPECT studies that 
show decreased regional brain perfusion (Honda et 
al., 2007), an absence in perfusion changes (Ushida 
et al., 2010), and increased perfusion changes (Cesaro 
et al., 1991). Wasan and colleagues, studied chronic 
back pain with ASL reported worsening of ongoing 
pain associated with significant regional blood flow 
increases within brain regions known to activate with 
experimental pain, among others (Wasan et al., 2011). 
Furthermore, deep brain interventions for chronic 
neuropathic pain in different regions involved in pain 
processing, describe dissimilar effects depending 
on localisation regarding post-procedure perfusion 
changes (Pereira et al., 2007). We have found increased 
perfusion in primary somatosensory cortex in chronic 
pain processing/secondary plasticity comparing MS 
patients with and without pain, in line with the findings 
of chronic pain associated with conditions other 
than MS. Another issue, that adds to this discussion, 
further supports novel and directed investigation of 
pain in MS with perfusion methods, is the recent 
focus on cerebrovascular abnormalities of underlying 
MS (D’haeseleer et al., 2011). Three types of vascular 
dysfunction have been identified: higher risk for 
ischaemic stroke, global cerebral hypoperfusion, and 
impairment of venous drainage from the CNS (this 
last theory not without controversy) (D’haeseleer et 
al., 2011).
For several of the measures we only found significant 
differences in the RR subgroup. This may reflect 
pathophysiological differences between MS subtypes 
of the disease, as described by Kutzelnigg and 
collaborators (Kutzelnigg et al., 2005). In their work 
new and active focal inflammatory demyelinating 
lesions in the white matter were mainly present in 
patients with acute and relapsing MS, while diffuse 
injury of the NAWM and cortical demyelination were 
characteristic of primary and secondary progressive 
MS. Further research is needed, especially in 
progressive MS, to establish possible particularities 
in their neuropathic pain characteristics, mechanisms 
and effects in the CNS.
5. Conclusion
This study involved the integration of behavioural 
and psychophysical results with multimodal brain and 
spinal cord MRI to investigate the possible mechanisms 
behind central pain in MS. Our comprehensive 
MRI protocol was designed to address the clinical-
radiological paradox that is often observed in MS. 
The psychophysical results from our study are in 
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concordance with previous research, suggesting that 
the phenotype of neuropathic central pain in MS is 
identical to other central pains. However, our study 
also suggests that even though thalamic lesions may 
be common in MS, the lesions that are more likely to 
cause pain in MS are in the spinal cord.
We have found several measures of brain structural 
and functional dysfunction: the increased connectivity 
between brain regions involved in pain processing, 
and in pain patients a decreased volume of NAWM, 
myelin disorganisation, and increased perfusion in the 
primary somatosensory cortex. We believe the brain 
changes we have identified are not contributions of 
pain, but instead may be the consequences of chronic 
pain originating in the spinal cord in MS.
This study raises interesting questions regarding the 
origin and consequences of neuropathic pain in MS, 
allowing hypotheses to be tested a priori in future MS 
pain studies.
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2.5. CHRONIC PAIN DISRUPTS THE REWARD CIRCUITRY IN MULTIPLE 
SCLEROSIS
2.5.1. Introduction
Similarly to other pain syndromes, pain in MS has the potential to become 
chronic, i.e. “pain that has persisted beyond normal tissue healing time” (Merskey 
H and Bogduk N, 1994), and burden an already damaged CNS. In fact, increasing 
evidence supports the notion that chronic pain can be understood not only as 
an altered functional state, but also a consequence of neuronal reorganisation 
(Baliki MN et al, 2011a; Rodriguez-Raecke R et al, 2009). Studies in animal models 
have demonstrated that chronic pain is accompanied by molecular, neuronal, and 
structural changes in the periphery and the spinal cord (Julius D and Basbaum 
AL, 2001).
Recent anatomical and functional imaging studies in humans are providing 
insights into brain restructuring associated with chronic pain. Altered brain 
structure was first demonstrated for back pain patients (Apkarian AV et al, 2008) 
and is now reported in many pain conditions, including fibromyalgia (Luerding R et 
al, 2008), CRPS (Geha PY et al, 2008), osteoarthritis (Gwilym SE et al, 2009), among 
others. Across human studies, regional increases, decreases and no change in 
grey matter in pain patients have been reported, and even though many studies 
emphasise involvement of brain regions associated with pain processing, other 
data also suggest that unique brain regions may be involved in different types of 
chronic pain (Baliki MN et al, 2011a).
Regarding functional brain plastic changes in long-standing pain, different 
chronic pain conditions seem to evoke distinct brain activity patterns, which may 
reflect not only pain but also processes related with each disease (Apkarian AV 
et al, 2009). In addition there is growing evidence that chronic pain alters brain 
dynamics beyond pain perception by distorting brain RSNs (networks of brain 
regions that are active when the individual is not focused on the outside world and 
the brain is at wakeful rest) (Baliki MN et al, 2008; Cauda F et al, 2010; Tagliazucchi 
E et al, 2010). Baliki and colleagues studying a group of chronic back pain patients 
found that these patients displayed reduced deactivation in several key default-
mode regions, suggesting that this disruption may underlie the cognitive and 
behavioral impairments accompanying chronic pain (Baliki MN et al, 2008). Again 
in chronic back pain patients, the impact of the presence of chronic pain on 
brain oscillatory activity in humans was investigated; patients showed increased 
62
THE RELATIONSHIP BETWEEN CHRONIC PAIN AND NEUROPSYCHIATRIC AND 
NEUROPSYCHOLOGICAL DISTURBANCES IN MULTIPLE SCLEROSIS
frequency oscillations circumscribed mainly to the medial prefrontal cortex (Baliki 
MN et al, 2011b). In another study on diabetic neuropathic pain, impairment in a 
parieto-fronto-cingulate network, thought to control attention to external stimuli, 
was demonstrated at rest (Cauda F et al, 2010).
Our objective was to study the probable disruption of the RSNs in chronic 
neuropathic pain of MS, and to investigate if there was a specific signature of 
functional interference in chronic pain of this disease, and relate these to possible 
structural brain changes. To the best of our knowledge there are no studies 
investigating resting functional connectivity in MS pain.
2.5.2. Methods
A case-control study was designed that included 23 MS patients attending the 
MS clinic at the John Radcliffe Hospital in Oxford, United Kingdom. The patients 
were between 18 and 55 years of age, had a definitive diagnosis of MS (according 
to the revised McDonald criteria (Polman CH et al, 2005)), and no contraindications 
for MRI. The case (pain) group consisted of 12 consecutively recruited patients 
with chronic (more than three month duration) central neuropathic pain. A control 
group of 11 MS patients without pain matched the case patients with respect to age, 
gender, subtype and duration of MS and EDSS score (Kurtzke JF, 1983). Patients 
with serious cognitive impairment, depression or fatigue, or with other neurological 
diseases, cancer, diabetes or renal disease were excluded. Forty-four patients were 
contacted; 21 patients declined to participate or did not meet the inclusion criteria. 
The Oxfordshire Research Ethics Committee approved the study.
The patients completed a number of self-administered questionnaires: Hospital 
Anxiety and Depression Scale (HADS) (Zigmond AS and Snaith RP, 1983), The Medical 
Outcome Study Short Form 36 (SF36) (Aaronson MK et al, 1998), Modified Fatigue 
Impact Scale (MFIS) (Fisk JD et al, 1994), and MS Neuropsychological Screening 
questionnaire (MSNq) (Benedict RH et al, 2003). Individuals with pain completed 
the short version of the Brief Pain Inventory (BPI) (Osborne TL et al, 2006). For a 
detailed description of the applied measures, please see the references.
2..2.1. Resting-state functional magnetic resonance imaging
Resting-state fMRI is a relatively novel technique that has several potential 
advantages over task-activation fMRI in terms of its clinical applicability, particularly 
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for ongoing pain states. Even at rest, the brain’s different functional networks 
spontaneously fluctuate in their activity level, and this activity is believed not to 
be random. Each network’s spatial extent can be mapped by finding temporal 
correlations between its different regions (Smith SM et al, 2012).
Several RSNs (Figure 4) were previously identified by independent component 
analysis (ICA), that included the somatomotor cortex, the primary and extrastriate 
visual cortex, the auditory cortex, a network implicated in executive control and 
salience processing, two lateralised fronto-parietal RSNs implicated in working 
memory and attentional processes, and the so-called DMN, deactivated during 
demanding cognitive tasks and involved in internal modes of cognition, and believed 
to be important in planning the future and in social interactions (Beckmann CF 
et al, 2005; Buckner RL et al, 2008; Cole DM et al, 2010; Damoiseaux JS et al, 
2005). Also, it seems that these RSNs closely relate to the underlying anatomical 
connectivity (Van den Heuvel MP et al, 2009).
 
figure 4. Spatial maps representing the eight resting-state networks, as indicated in blue-lightblue colours: 
(a) primary visual cortex, (b) extrastriate visual cortex, (c) auditory and other sensory association cortices, 
(d) somatomotor cortex, (e) default mode network, (f) executive control, and (g, h) lateralised fronto-parietal 
cortex. Regions belonging to the default-mode network included the medial prefrontal cortex, the anterior 
and posterior cingulate cortex, lateral and inferior parietal cortex, inferior and middle temporal gyri and 
mesial temporal lobe regions, the precuneus, the thalami, and cerebellar areas. The coordinates refer to mm 
distances from the anterior commissure and images are shown in radiological convention. Reproduced with 
permission from Beckmann et al., 200.
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Imaging was conducted using a 3 t MRI scanner (Siemens TIM Trio) and 
a 12-channel head coil, in a single session. For each patient, 100 volumes of 
whole head functional data were acquired with typical fMRI resolution (TR=3000 
ms, TE=30 ms, 3x3x3 mm). In addition, a structural MRI sequence covering the 
whole brain (T1-weighted magnetisation prepared rapid acquisition gradient 
echo – MPRAGE) (Mugler JP and Brookeman JR, 1990) was also acquired for the 
purpose of anatomical localisation (TR=2040 ms, TE=4.7 ms, 1x1x1 mm). Subjects 
were instructed to keep their eyes closed and not to fall asleep during functional 
scanning.
The preprocessing of the images was carried out using FEAT (FMRI expert 
analysis tool), part of FSL (FMRIB’s Software Library; www.fmrib.ox.ac.uk/fsl) 
(Smith SM et al, 2004). The following processing steps were applied: motion 
correction (Jenkinson M et al, 2002), removal of non-brain tissue (Smith SM, 
2002), spatial smoothing using a Gaussian kernel of 6-mm full width at half 
maximum, grand-mean intensity normalisation of the entire 4D dataset by a 
single multiplicative factor, high-pass temporal filtering (gaussian-weighted 
least-squares straight line fitting, with a cut-off of 150s) and registration to the 
high resolution T1-MPRAGE and MNI152 standard space (Montreal Neurological 
Institute, Montreal, qC, Canada) (Jenkinson M and Smith S, 2001; Jenkinson M 
et al, 2002). Normalised 4D data sets were subsequently resampled to 2-mm 
isotropic voxels to reduce computational burden in the following analysis steps.
The between subject analysis of the resting data then proceeded in three 
stages. Firstly, the fMRI data sets of all the subjects were concatenated temporally 
and probabilistic ICA (Beckmann CF et al, 2005) was applied in order to identify 
21 components representing group-averaged networks of brain regions with fMRI 
signals that were temporally correlated; secondly, dual regression was used to 
identify, within each individual fMRI data set, corresponding temporal dynamics and 
associated spatial maps (as previously described in: Cole DM et al, 2010; Filippini 
N et al, 2009). This involved using the group maps in a linear model fit, resulting 
in matrices describing temporal dynamics for each component and subject and 
using these matrices in a linear model fit to estimate subject-specific spatial maps. 
Finally, eight RSNs (Figure 4) were selected out of the 21 components obtained with 
ICA, that were identified as anatomically and functionally relevant upon correlation 
with the RSNs identified previously by Beckmann and colleagues (Beckmann CF et 
al, 2005), obtained by discarding artifactual maps (residual motion, mal-alignment, 
and other noise sources), and selected by having signal within the low frequency 
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range of 0.1–0.01 Hz (Cordes D et al, 2001; Lowe MJ et al, 1998), connectivity 
patterns mainly located in gray matter, and presence of coherent clusters of voxels 
(De Martino F et al, 2007). The different selected component maps were collected 
across subjects into single 4D files (one per original map) and analysed using non-
parametric permutation testing (FSL’s Randomize tool, (Smith SM and Nichols 
TE, 2009)), to compare the identified RSNs between pain and no-pain groups. For 
each RSN, the resulting statistical maps were thresholded at p<0.05 (cluster-based 
thresholding, corrected for multiple comparisons).
2..2.2. Volume of subcortical structures
The volume of the caudate nucleus and the nucleus accumbens was 
measured; these structures were segmented using FIRST (FMRIB’s integrated 
registration and segmentation tool), part of FSL (Patenaude B et al, 2011). The 
high resolution T1-MPRAGE were first registered nonlinearly to the standard 
MNI152 space using FNIRT (FMRIB’s nonlinear image registration tool). The 
registered images were then processed with FIRST to extract the surface mesh 
of the subcortical nuclei. The surfaces in the warped space were then unwarped 
to the original MRI space, and then filled and boundary corrected. Finally, the 
volume of the caudate nucleus and the nucleus accumbens was measured in 
cubic millimeters. Comparisons between MS patients with and without pain were 
carried out using unpaired t-tests (SPSS 18.0 Inc).
2..2.3. Voxel-based morphometry
Voxel-based morphomerty (VBM) is a flexible whole-brain statistical analysis 
technique that can be used to assess between-group differences in regional brain 
grey matter content.
Structural data were analysed using FSL-VBM (part of FSL), a voxel-based 
morphometry style analysis (Ashburner J and Frinston KJ, 2000; Good CD et 
al, 2001). First, structural images were brain-extracted (Smith SM, 2002). Next, 
tissue-type segmentation was carried out using FAST (FMRIB’s automated 
segmentation tool) (Zhang Y et al, 2001). The resulting grey matter partial volume 
images were then aligned to MNI152 standard space using FLIRT (FMRIB’s 
linear image registration tool) (Jenkinson M and Smith S, 2001; Jenkinson M et 
al, 2002), followed by nonlinear registration using FNIRT. The resulting images 
were averaged to create a study-specific template, to which the native grey 
matter images were then nonlinearly registered. The registered partial-volume 
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grey matter images were then modulated (to correct for local expansion or 
contraction), by multiplying them with the Jacobian of the warp-field. Finally, the 
modulated segmented images were smoothed with an isotropic Gaussian kernel 
with a sigma value of 3 mm.
To achieve accurate inference including full correction for multiple 
comparisons over space, we used permutation-based nonparametric inference 
within the framework of the general linear model to investigate changes in the 
distribution of gray matter (5000 permutations) (Smith SM and Nichols TE, 2009). 
Cross-sectional statistical comparisons between MS patients with and without 
pain were carried out using unpaired t-tests. P values less than 0.05, corrected for 
multiple comparisons (after initial cluster-forming thresholding at uncorrected 
p=0.05), were considered significant. Alternatively, and where stated, results were 
uncorrected for multiple comparisons (p<0.05).
2.5.3. Results
The group of MS patients with chronic neuropathic pain consisted of 10 females 
and two males, and the control group (no pain) consisted of nine females and two 
males. Mean age was 48.4 years (SE 2.7) and 46.9 years (SE 2.5), mean duration of 
the disease (from time of first symptoms) was 13.3 years (SE 2.8) and 12.3 years 
(SE 2.1), and mean EDSS was 4.8 (SE 0.6, median 5.3, min 1, max 8) and 4.7 (SE 0.6, 
median 4.5, min 1.5, max 8), for the pain and control groups, respectively. Regarding 
the distribution of patients according to MS subtype, in each group seven patients 
had relapsing-remitting (RR) MS and four patients secondary progressive MS; one 
patient in the pain group had primary progressive MS. There were no statistical 
differences between groups for gender (p=0.924), age (p=0.657), MS duration 
(p=0.951), and EDSS score by categories (0.0-4.5 and 5.0-9.5) (p=0.827). A summary 
of the patient demographics and clinical characteristics is provided on Table 1.
Mean duration of pain was 7.6 years (SE 2.5, median 4.5) and mean pain 
intensity was 5.5 on an 11-point scale (SE 0.3, median 5.0). The control group 
had better general health than the case group (p=0.003); pain interfered with 
walking, work and sleep (BPI). In comparison to controls, pain patients were more 
depressed (p=0.0046). No difference was found pertaining to anxiety (p=0.2838), 
fatigue (p=0.197) or cognitive impairment (p=0.2838) between groups.
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Comparing the eight RSNs (Figure 4) between the pain and no-pain groups, 
statistical differences were found only for the DMN, revealing decreased coactivation 
in the caudate nucleus and nucleus accumbens bilaterally (p<0.05, corrected for 
multiple comparisons), illustrated in Figure 5. There were no differences regarding 
the volume of the caudate or accumbens nuclei (p=0.58 and p=0.65, respectively).
Table 1. Demographic and clinical characteristics of the MS patient sample.*
  Pain group Control group
Mean age in years n.s. 48.4 (2.7) 46.9 (2.5)
Gender n.s.  
 Male n=2 n=2
 Female n=10 n=9
Mean education in years 12.8 (1.1) 14.9 (0.9)
Race/ethnicity  
 Caucasian n=12 n=11
Marital status  
 Married or living as married n=6 n=9
 Single n=2 n=2
 Divorced n=4 n=0
 Widowed n=0 n=0
Mean disease duration in years n.s. 13.3 (2.8) 12.3 (2.1)
Mean years since diagnosis n.s. 6.3 (1.6) 10.2 (1.9)
Mean EDSS score n.s. 4.8 (0.6) 4.7 (0.6)
MS subtype  
 Relapsing-remitting n=7 n=7
 Secondary progressive n=4 n=4
 Primary progressive n=1 n=0
figure 5. Default-mode network comparison between the pain and no pain groups revealed decreased 
coactivation in the caudate nucleus and nucleus accumbens bilaterally, as indicated in red-to-yellow colours 
(p<0.05, corrected for multiple comparisons). The coordinates refer to mm distances from the anterior 
commissure and images are shown in radiological convention.
68
THE RELATIONSHIP BETWEEN CHRONIC PAIN AND NEUROPSYCHIATRIC AND 
NEUROPSYCHOLOGICAL DISTURBANCES IN MULTIPLE SCLEROSIS
There were no whole brain differences between MS pain and no-pain groups 
regarding grey matter density, however for the RR subgroup of patients, at p<0.05 
uncorrected, interesting grey matter thickness gradients were noted (Figure 6). 
The grey matter changes predominated in the pain group in the mesial region of 
the temporal lobes, in the basal ganglia (caudate and putamen), the thalami and 
the fronto-parietal cortex, including association and somatomotor areas; in the 
group without pain, brain changes predominated in the frontal lobes (frontopolar 
and orbitofrontal cortices), and in the occipital areas.
 
figure 6. Whole-brain cross-sectional analysis of grey matter volume in MS pain subjects and in MS patients 
without pain. Areas of grey matter density changes in pain patients comparing to controls are shown in red-
to-yellow colours, and areas of grey matter density changes in controls comparing to pain patients are shown 
in blue-lightblue colours (uncorrected p<0.05). Images shown are, from left to right, y=52, 38, 18, -4 and -68 
mm (distances from the anterior commissure; images are shown in radiological convention).
2.5.4. Discussion
It remains unclear whether brain reorganisation in chronic pain exclusively 
impacts on the pain processing circuitry and whether the sites of local reorganisation 
mirror specific patterns of brain functional states seen for distinct types of chronic 
pain or pathologies underlying these pain syndromes. Baliki and colleagues 
compared using structural MRI global, local, and architectural changes in grey 
matter properties in patients suffering from chronic back pain, CRPS, and knee 
osteoarthritis relative to healthy controls, finding that different chronic pain types 
exhibited unique anatomical brain signatures, although there was a common set of 
regions across all conditions (Baliki MN et al, 2011a). Moreover, the structural brain 
changes in chronic pain in humans reflect the altered functional CNS physiology in 
chronic pain, including, as seen before, the brain RSNs, more frequently the DMN 
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(Baliki MN et al, 2008; Baliki MN et al, 2011b; Cauda F et al, 2010; Tagliazucchi E 
et al, 2010). In our study, comparing MS patients with and without chronic pain, 
we have found functional and structural brain differences that involve the reward 
circuitry: the caudate nucleus, the nucleus accumbens, and the mesial temporal 
lobe. The ventral striatum, including the nucleus accumbens and the caudate 
nucleus, is connectionally associated with the limbic structures and the prefrontal 
cortex, and is involved in motivational and emotional aspects of behaviour, including 
reward, important for planning and decision-making (Dehaene 2000; O’Doherty JP, 
2004). Interestingly, on the other hand, the MS patients without pain seem to have 
higher cortical density mostly in frontal areas, including the orbitofrontal and the 
frontopolar cortices. Becker and colleagues reviewing the cerebral interactions 
of pain and reward and their relevance for chronic pain, stress that pain and 
reward share some neuroanatomical and neurochemical systems, and separate 
the cerebral processing of hedonic and motivational aspects of reward: the 
orbitofrontal cortex and opioids with an important role in the hedonic experience, 
and the ventral striatum and dopamine predominantly processing motivation for 
reward (Becker S et al, 2012). Hence, further scrutinising our results, it could be 
hypothesised that the functional and structural brain disruption associated with 
chronic pain observed in our MS patient sample involved mostly the areas related 
to motivational (‘wanting’) effects on pain.
Baliki and colleagues addressed the role of the motivation/valuation circuitry 
in chronic pain (Baliki MN et al, 2010). They compared brain activation in response 
to acute noxious thermal stimuli in controls and chronic back pain patients. Pain 
perception and related cortical activation patterns were similar in the two groups, 
however, nucleus accumbens activity differentiated the groups; the authors 
suggested that in contrast to somatosensory pathways, which reflected sensory 
properties of acute noxious stimuli, the nucleus accumbens activity reflected the 
prediction of worsening of the ongoing back pain in the patients, while in normals 
it reflected the prediction of relief (Baliki MN et al, 2010). Pain relief is a rewarding 
stimulus that appears to be particularly important in the context of pain (Leknes 
S et al, 2011). It is also possible that the transition from acute to chronic pain 
represents a dysfunctional associative learning process emanating in part from 
predictions, valuations, and related motivations and mediated by distinct circuitry 
involving connections with the nucleus accumbens (Apkarian AV, 2008). Other 
evidence of the involvement of the reward circuitry in chronic pain was the finding 
of grey matter atrophy in the right insula, ventromedial prefrontal cortex, and 
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nucleus accumbens in chronic CRPS patients (Geha PY et al, 2008). Also, an 
increase in grey matter in the basal ganglia has been reported in chronic back 
pain patients (Schmidt-Wilcke T et al, 2006), in fibromyalgia (Schmidt-Wilcke T 
et al, 2007), and in chronic vulval pain (Schweinhardt P et al, 2008), suggesting 
some underlying functional alterations that drive these changes. In other chronic 
pain conditions, alterations in activation in basal ganglia regions have been 
demonstrated (Becerra L et al 2006; Becerra L et al, 2009) where stimulation 
to the affected neuropathic regions produces significant activation in the basal 
ganglia.
Further research is needed to drive a deeper understanding of the meaning 
and consequences of the dysfunction in the reward system found in chronic pain of 
MS, especially because cognition and emotion disorders are similarly prevalent in 
MS, and altered decision-makingin the evaluation of outcomes related with reward 
an punishment have already been addressed in the literature in MS individuals not 
associated with pain (Kleeberg J et al, 2004; Nagy H et al, 2006).
Disruptions of resting-state connectivity non-associated with pain have 
also been reported in MS, in particular of the DMN, mostly related to cognitive 
impairment of MS (Bonavita S et al, 2011; Hawellek DJ et al, 2011; Rocca MA 
et al, 2010). Comparing MS patients with and without cognitive impairment, 
differences were found in the anterior areas of the DMN, namely the medial 
prefrontal cortex, the precentral gyrus, and the anterior cingulate cortex (Rocca 
MA et al, 2010). Bonavita and colleagues reported a dysfunction of the DMN in 
MS patients when compared to healthy controls in the anterior cingulate cortex, 
and attributed posterior cingulate cortex differences to a possible compensatory 
effect on cognitive performance (Bonavita S et al, 2011). It is likely then, as 
demonstrated with cognitive impairment and now with chronic pain, that many of 
the MS symptoms/related conditions will in turn have an effect on the functional 
connectivity of the brain at rest, as they seem to have on its structure.
In comparison to controls, our pain patients were more depressed; no 
difference between groups was found regarding anxiety, fatigue or cognitive 
impairment. Depression not related with any other concomitant pathology has 
been found to be associated with both stimulus-induced heightened activity and 
failure to normally down-regulate activity broadly within the DMN (Sheline YI et 
al, 2009). Also, Bluhm and colleagues reported decreased connectivity between 
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the precuneus and posterior cingulate cortex and bilateral caudate in early 
depression (Bluhm R et al, 2009). Depression is thought to be responsible as well 
for neuroanatomical changes that include reduced volume of the basal ganglia, 
thalamus, hippocampus, frontal lobe, orbitofrontal cortex, and gyrus rectus 
(Kempton MJ et al, 2011). In the context of chronic pain and depression more 
functional studies examining the resting brain, in particular the DMN, supported 
by structural data, are needed. This problem is however difficult to extricate 
because psychological comorbidity is a frequent complication of long-standing 
pain: chronic pain is known to significantly predict the onset of depression, and 
depression significantly predicts the onset of chronic pain (Tunks ER et al, 2008).
2.5.5. Conclusion
We have demonstrated a dysfunction in the reward system in chronic pain 
of MS, particularly in the brain areas involved in its motivational aspects, as 
such probably reflecting the functional and structural maladaptive physiology 
of chronic pain, and possibly a unique signature of MS pain, in a disease where 
reward impairment seems to be already one of its features. More studies are 
needed to investigate if these reward system alterations are MS-specific, and to 
further understand the role of possible synergies with depression and cognitive 
impairment, also common in MS.
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3.1. DISCUSSION
The present thesis began by demonstrating that pain is a frequent symptom 
in a Portuguese sample of 85 MS patients, with an estimated prevalence of 34% 
(Seixas D et al, 2011), which is in accordance with the prevalence found in other 
European countries (Boneschi FM et al, 2008; Stenager E et al, 1991; Vermote R et 
al, 1986). Moreover, pain interfered significantly with the qOL of these patients.
Notwithstanding the high prevalence of pain in MS and the abundance of 
descriptive studies in the field, we have found in our systematic review of the 
literature on neuroimaging studies investigating pain in MS, that data on its 
mechanisms and consequences are scarce (Chapter 2.2). The majority of the 
studies retrieved were small and aimed mostly at reporting neuroradiological 
associations of pain.They all focused on neuropathic pain, and in particular on the 
headache and facial pain niche, leaving aside most of the other pain syndromes 
described for MS (O´Connor AB et al, 2008). This review was important in providing 
the context of our neuroimaging project (Chapters 2.4 and 2.5).
Among the various MS possible pain conditions (central neuropathic pain, 
painful tonic spasms, back pain, headache, and CRPS), we chose to study chronic 
central pain because it is thought to be the most common pain syndrome in MS, 
with an estimated prevalence of 27.5% (Osterberg A et al, 2005), and is originated 
directly by MS pathological mechanisms. Furthermore, it severely impacts on 
patient functioning and is of difficult management (Fischer JS et al, 1999; Osterberg 
A et al, 2005).
Worthy of note is the existence of animal models of MS that also have 
been granting their contribution to the understanding of pain in this condition. 
Experimental autoimmune encephalomyelitis (EAE) is a model of monophasic 
brain inflammation, a prototype of T-cell-mediated autoimmune disease (Sriram 
S and Steiner I, 2005). Olechowski and collaborators showed that EAE mice 
immunised with myelin oligodendrocyte glycoprotein developed allodynia to 
both cold and tactile stimuli. There was a significant influx of CD3+ T cells and 
increased astrocyte and microglia/macrophage reactivity in the superficial dorsal 
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horn of these mice suggesting that inflammation and reactive gliosis may be key 
mediators of allodynia in EAE, similar to peripheral nerve and spinal cord injury 
models (Olechowski CJ et al, 2009). The same authors suggest that a deregulation 
of glutamate transporter function in EAE mice may be an important mechanism 
underlying the abnormal pain sensitivity in response to persistent noxious 
stimulation (Olechowski CJ et al, 2010).
Looking at our MS patient sample (12 patients with chronic central pain, 
and 11 patients without pain matched for age, gender, subtype and duration of 
MS and disability), pain patients were more depressed and hypervigilant, and had 
worse general health and qOL. qST revealed that temperature abnormalities in 
these patients were the most frequent. Thus, the phenotype of chronic central 
pain of MS did not differ phychophysically from other central neuropathic pain 
syndromes, as already reported by Osterberg and co-workers (Osterberg A et al, 
2005; Osterberg A and Boivie J, 2010).
Regarding the mechanisms of pain in these patients, lesion location that 
most often explained pain was the spinal cord. Finding that MS central pain may be 
caused largely by spinal cord plaques, is of great importance for future research 
and for the treatment of pain in MS, in better targeting drugs and interventions, 
such as deep brain or cord stimulation. A surprising finding was that thalamic 
lesions were common among patients with and without pain. It is known that the 
thalamus is a frequent source of central pain, particularly the ventroposterior 
nuclei (Boivie J, 2011). However, only one patient of our sample had a thalamic 
pain syndrome, and most of the lesions found, both in the pain and no pain groups, 
were medially located in the thalamus.
Concerning possible consequences of chronic neuropathic pain in MS, we 
have showed evidence of brain structural and functional dysfunction: increased 
connectivity between brain regions involved in pain processing, a decreased 
volume of NAWM, myelin disorganisation and increased perfusion in the primary 
somatic area. We believe these plastic, probably maladaptive, brain changes 
may be a contribution of chronic pain, and furthermore, a consequence of pain 
originating in the spinal cord in MS.
Further examining functional changes in the context of central chronic 
pain of MS, we have investigated its impact on the brain resting-state networks – 
networks of brain regions that are active when the individual is not focused on the 
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outside world and the brain is at wakeful rest (Baliki MN et al, 2008; Cauda F et al, 
2010; Tagliazucchi E et al, 2010).The DMN, one of such networks, is deactivated 
during demanding cognitive tasks and involved in internal modes of cognition. 
It is believed to be important in planning the future and in social interactions 
(Beckmann CF et al, 2005). It was interesting to find a DMN dysfunction in regions 
subserving the reward system (particularly its motivational aspects – caudate 
nucleus and nucleus accumbens), suggesting altered decision-making in these 
patients. These changes may reflect the uniqueness of MS pain, as there is 
evidence of different chronic pain conditions inducing distinct brain activity and 
structural patterns, which may reflect not only pain but also specific processes of 
each disease (Apkarian AV et al, 2009).
The main project limitation was the difficulty of achieving enough MS patient 
numbers to fulfil the stringent exclusion and inclusion criteria of the chronic 
central pain study, and yet recruitment lasted 18 months. The duration of the 
study sessions was also a limitation in defining the study methodology, since long 
patient visits and scanning times had to be avoided.
Avoiding long scanning times conditioned the MRI protocol, especially 
because imaging both the spinal cord and the brain was fundamental in assessing 
completely the CNS in the context of pain research. Designing this protocol, so 
that the mechanisms and consequences of chronic central pain in MS could be 
investigated, was a challenge. This was circumvented with multimodal MRI, aimed 
at capturing MS visible and invisible pathology, studying both white matter and 
grey matter. Structural MRI included a T1-weighted volumetric sequence with 
great anatomic detail and essential for registration purposes; a proton density-T2 
sequence for evaluation of the white matter in general and the brainstem and the 
cerebellum in particular; a T2 FLAIR sequence, which removes the CSF signal, 
important to increase conspicuity of periventricular lesions; and a DIR sequence 
with suppression of both the CSF and white matter signals, that allows better 
identification of cortical lesions (Wattjes MP et al, 2007). For spinal cord structural 
imaging, T2 FSE images were acquired in the sagittal plane (thought to correlate 
well with the level of sensory impairment (Fukutake T et al, 1998)).To study the 
NAWM of MS, diffusion-based measures and myelin-selective T2 mapping (Laule 
C et al, 2004) techniques were used that offer insight on myelin and axonal integrity 
(Laule C et al, 2007). From a functional rather than a structural perspective, we 
used ASL, a noninvasive method to measure brain perfusion with MRI, thought 
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as a biomarker of regional brain function (Detre JA et al, 2009). Finally, resting-
state fMRI was used, an MRI technique that has several potential advantages over 
task-activation fMRI in terms of its clinical applicability, particularly for ongoing 
pain states (Baliki MN et al,2006). This comprehensive neuroimaging protocol was 
supported by a thorough psychophysical evaluation, including qST.
Another study limitation was the use of two patient cohorts, Portuguese (MS 
clinic, Centro Hospitalar São João, Porto) and British (MS clinic, John Radcliffe 
Hospital, Oxford). The British patient sample was a consequence of the need to 
obtain expertise and support in pain neuroimaging (Pain Imaging Neuroscience 
Group, Oxford Centre for Functional Magnetic Resonance Imaging of the Brain).
3.2. CONCLUSIONS
Our work allowed us to further characterise, as well as identify underlying 
mechanisms and consequences of chronic central pain of MS. Most relevantly 
and not previously shown before, we have presented a high prevalence of pain 
with a significant impact in patient functioning in a Portuguese MS cohort. 
Psychophysically, chronic central neuropathic pain of MS behaved identically 
to other modalities of central pain. However, neuroimaging data suggests the 
following particular features of pain of MS.
Regarding topography of MS plaques responsible for the central pain 
syndromes, the spinal cord seems to be a frequent origin of central pain in MS. On 
the other hand, thalamic lesions, although common and with a singular tropism 
for the medial thalamus, were seldom the probable cause of pain.
Structural and functional brain changes related to chronic central pain of MS 
were found, with significant increases in connectivity between the thalamus and 
the cingulate and insular cortices, areas involved in pain processing. The volume 
of NAWM was reduced in pain patients and myelin measures correlated with 
pain, pointing to myelin disorganisation in this group. Functional abnormalities 
in MS pain were suggested by increased perfusion in the somatosensory cortex. 
Most interestingly, there was an apparent disruption of there ward system when 
studying the DMN in these patients, hinting planning, social and decision-making 
problems in MS patients with pain.
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In conclusion, central neuropathic pain in MS may originate from a single 
lesion in the somatosensory pathway, possibly the spinal cord, and evolve into 
chronic pain, burdening an already MS-damaged CNS and leading to a cycle of 
structural and functional brain disruption, most eloquently of the reward system 
(Figure 7). This is the context that is perhaps unique to MS, which mechanisms 
we tried to capture using a state-of-the-art imaging protocol directed at the 
specificities of this demyelinating disease.
figure 7. The cycle of structural and functional central nervous system damage of pain in multiple sclerosis.
3.3. fUTURE PERSPECTIVES
Future studies aiming to address the problem of chronic pain in MS should 
focus on comparing MS central pain with other central pain syndromes by 
assessing directly common and distinctive features. Correspondingly, it would be 
of interest to investigate nociceptive pain of MS (neglected in the literature as seen 
in Chapter 2.2), a pain syndrome potentially easier to prevent from transforming 
into chronic pain.
Spine pathology in MS patients with pain should be further explored taking 
advantage of the advances in MRI of this region anatomically and technically 
difficult to image, particularly fMRI (Kong Y et al, 2012) and diffusion MRI (Bosma 
R and Stroman PW, 2012).
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Although thalamic lesions seem not to be an important source of MS central 
pain, it would be interesting to know why there is a predilection of MS plaques for 
the medial thalami.
Additionally, more studies are needed to investigate the interaction of MS and 
pain common comorbidities like depression, cognitive impairment and fatigue, 
and to elucidate the behavioral consequences of the dysfunction of the reward 
system in chronic pain of MS.
Lastly, it would be important to know more about pain in Portuguese MS 
patients, in what this thesis was only the beginning, to advance pain management 
in this cohort of patients.
There are also emerging MRI techniques and technologies for the study 
of MS pathology, that may prove of interest in the particular research field of 
pain in this disease, possibly providing better correlations with psychophysical 
measures of pain: new iron-based MRI contrast agents able of tracking peripheral 
macrophages, providing complementary information on MS-related active 
inflammation (Dousset V et al, 2006), and magnetic resonance iron-imaging – a 
link has already been established between iron deposition, grey matter damage 
and clinical status (Stankiewicz J et al, 2007). Moreover, MRI at ultra high field 
affords advantages in signal to noise ratio, image contrast and resolution, 
although not without technical challenges. Imaging at 7 t was demonstrated to be 
safe and well tolerated, and provided high-resolution anatomical images allowing 
visualisation of structural abnormalities located within or near the cortical layers 
(Mainero C et al, 2009). Besides, ultra high field imaging has greater sensitivity 
to localise iron deposition (Hammond KE et al, 2008); it also benefits magnetic 
resonance spectroscopy, providing insights into neurodegeneration, tissue repair, 
and oxidative stress in MS (Srinivasan R et al, 2010), as does fMRI, probing the 
cortical columns (Smith SM, 2012).
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